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ABSTRACT OF THE DISSERTATION 
The Single Cell Transposome Hypersensitive Sites Sequencing (scTHS-
seq) assay for Chromatin Accessibility and Assessment of Epigenetic 
States in the Human Adult Brain 
 
 
by 
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University of California, San Diego, 2017 
 
 
 
Professor Kun Zhang, Chair 
 
 Chromatin accessibility captures in vivo protein-chromosome binding 
status, and is considered an informative proxy for protein-DNA interactions. 
DNase I and Tn5 transposase assays require thousands to millions of fresh cells 
for comprehensive chromatin mapping. Applying Tn5 tagmentation to hundreds 
of cells and to single cells results in sparse chromatin maps at high throughput or 
 xvi 
 
dense chromatin maps at low throughput. We present a high throughput 
transposome hypersensitive sites sequencing assay for highly sensitive 
characterization of chromatin accessibility. Linear amplification of accessible 
DNA ends with in vitro transcription, coupled with an engineered Tn5 super-
mutant, demonstrates improved sensitivity on limited input materials, and 
accessibility of small regions near distal enhancers, compared with ATAC-seq. 
Application to single cells was achieved by adapting THS-seq to combinatorial 
indexing to generate high sensitivity DNA accessibility maps for tens of 
thousands of single cells from the human adult visual and frontal cortex. 
Integrative analysis of snDrop-seq and scTHS-seq has allowed us to identify 
transcription factors and regulatory elements shaping the state of different brain 
cell types, and to map genetic risk factors of common human brain diseases to 
specific pathogenic cell types and subtypes. Overall we demonstrate the viability 
of scTHS-seq to quantitate DNA accessibility in single cells, and application to 
biological samples to shed insight on human brain diseases. 
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CHAPTER 1: INTRODUCTION 
Chromatin accessibility assays and THS-seq 
The accessibility of chromatin is a major determinant of gene regulation. 
The chromatin landscape defines the transcriptional regulatory networks that 
determine cellular identity and function as well as biological processes involved 
in differentiation, proliferation, development and responses to the extracellular 
environment. Regulatory regions can be open or poised for regulation, when 
DNA within the region is accessible for factors to bind to DNA binding sites. 
Conversely, regulatory regions can be closed with DNA binding sites 
inaccessible, and thus not open for regulation. Genome wide chromatin 
accessibility assays were first developed utilizing cloning1, then microarrays2, and 
now existing assays such as, DNase-seq3, FAIRE-seq4 and ATAC-seq5 methods 
have been shown to be remarkably powerful in defining the binding status of 
transcription factors, determining nucleosome occupancy and constructing gene 
regulatory networks6-14. These assays measured DNA accessibility in bulk 
samples with loss of cellular resolution in treating tens of thousands to millions of 
cells as a single sample. In this case measurements reflect a sum of cellular 
heterogeneity with loss of ability to delineate chromatin accessibility in rare cell 
populations, or within multiple different cell populations in the same sample. 
However, assays have been developed to measure DNA accessibility at the 
single cell level, using the C1 microfluiditics chip, single cell DNase I 
accessibility, and combinatorial indexing15-17. Each method has its deficiencies, 
the C1 microfluidic chip and single cell DNase I assays are not high throughput, 
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and combinatorial indexing generates rather sparse data, such that the number 
of input cells and assay runs to obtain enough single cell data for analysis 
outweighs the monetary and time costs per experiment. Considering the 
proprietary nature of the C1 instrument and chip design, and no clear path to 
improve the throughput of the DNase I assay, we focus on further improvement 
on the sensitivity of the tagmentation-based approach as well as the throughput. 
This will facilitate routine profiling of accessible chromatin on a wide variety of 
samples. 
The widely used DNase-Seq and ATAC-seq methods have several areas 
that can be improved upon to increase assay sensitivity. For DNase-seq millions 
of cells are required for nuclei isolation, DNase I titration, downstream enzymatic 
reactions and associated purification steps for DNA end polishing and adaptor 
ligations3. These inefficiencies were addressed by ATAC-seq and its usage of 
the Tn5 transposome system, which was originally developed for generating low 
input sequencing libraries18, 19. With this method, chromatin accessibility assays 
were demonstrated initially at the 50,000-cell level, and more recently with single 
cells with adaptation to the combinatorial indexing method15. However, with the 
ATAC-seq method, we identified three aspects that can be potentially improved 
to increase the assay sensitivity. Firstly, by design, the method uses PCR 
amplification immediately after Tn5 insertion, and only a fraction of the 
“tagmented” molecules can be amplified and recovered, as not all inserted 
adaptor pairs are in the correct orientation or have the appropriate spacing to 
generate molecules of a size amenable to PCR amplification. Second, buffer 
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conditions are critical for Tn5 activity, and critical components such as 
dimethylformamide (DMF) can be titrated for optimal Tn5 activity for assessing 
chromatin accessibility, as well as determining the optimal concoction of buffer 
components20. Thirdly, the commercial EzTn5 transposase is a mutated version 
of the wild-type Tn5 enzyme that has high activity for random transposition21, 22. 
There is potential room to further engineer the enzyme to achieve a more 
efficient and specific insertion into open chromatin. 
 
Combinatorial indexing and application to human brain cells 
Combinatorial indexing with Tn5 Transposition is a multiplexing method 
initially developed to process thousands of samples in a single experiment with 
96 well plates. Indexing is performed at both the transposition and PCR stages, 
which generates 9,216 possible barcode combinations. Initially developed for 
resolving haplotypes in whole genome samples23, the method has been applied 
to different single cell methods including DNA accessibility, Hi-C24-26 and most 
recently RNA-seq. With multiple rounds of indexing and adaptor addition, it has 
the potential to assay tens of millions of cells, with the rate limiting factors being 
the cost of sequencing and computational power for data analysis. No machines 
are needed and the method can be carried out using PCR plates and pipetting 
tools. Importantly, although Tn5 transposition cuts DNA, it does not fragment 
DNA until Tn5 is removed since it remains tightly bound to DNA after 
transposition. All tags remain within nuclei, which can then be re-
compartmentalized for secondary barcoding steps. THS-seq adaptation to 
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combinatorial indexing will allow high throughput data generation, and when 
combined with the higher sensitivity of THS-seq, will provide a powerful single 
cell chromatin accessibility method.  
 To our knowledge, deconvolution and identification of cell types has not 
been performed on single cell chromatin accessibility data obtained from a single 
heterogeneous sample. There has been a study performed on bulk samples that 
have been pre-sorted, computationally merged, and sorted into respective cell 
types again27. This provides proof of concept for deconvolution of cell types and 
shows there is enough heterogeneity in DNA accessibility data to do this 
analysis. However, this was on bulk samples and how the analysis translates to 
single cell chromatin accessibility data is unknown. Once deconvolution and 
identification of cell types is accomplished, then we can perform an integrative 
analysis of scTHS-seq and snDrop-seq data on human brain samples.  
 There have been several integrative analyses of RNA-seq data and DNA 
accessibility data finding novel biological insights28-30. However, these analyses 
have been performed on bulk datasets with tens of thousands cells, and a single 
cell integrative analysis has not been performed to our knowledge. Single cell 
RNA-seq technologies have made rapid advances and are able to generate tens 
of thousands of high quality single cell datasets, with methods including inDrop, 
Drop-seq and Split-seq31-33. Single cell chromatin accessibility assays have either 
had high sensitivity and low throughput, or high throughput and low sensitivity, 
thus not generating quality datasets to perform an integrative analysis with single 
cell RNA-seq data. With high quality scTHS-seq data containing thousands of 
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single cells, we are expecting to be able to perform an integrative analysis, 
generating a more complete regulatory map containing both chromatin 
accessibility data and transcriptional data. 
There are large repositories of GWAS data available online that have 
curated disease risk loci for complex diseases34, 35. This data has proved very 
useful in identifying risk alleles and explaining their contribution to disease36, 
however there is no direct way to predict susceptible cell types involved in 
disease. If an identified cell type has accessible chromatin, is expressed, or is 
epigenetically activated at disease risk loci, then it is more likely to be susceptible 
to disease, opposed to a cell under epigenetic repression at the same loci. We 
hypothesize that integration of scTHS-seq data and GWAS data will be able to 
reveal the most susceptible cell types in disease pathologies. 
In this dissertation we present a systematic effort to assay chromatin 
accessibility in single cells at high sensitivity. Initially we greatly increase the 
sensitivity of transposase-based DNA accessibility assays through optimization 
of method, buffer and enzyme. We show that we achieve high sensitivity and 
capture of more distal regulatory elements. To assay chromatin accessibility in 
single cells in a high throughput manner, we then adapt THS-seq to 
combinatorial indexing and apply the method to human brain visual and frontal 
cortex samples. We then develop an analysis method to identify and classify cell 
subtypes in single cell chromatin accessibility data from a heterogonous sample 
of unidentified cell types. Integrative data analysis with snDrop-seq data further 
identifies cellular subtypes and demonstrates a new strategy to construct atlases 
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of single cell data from human organs. Lastly, association with disease risk 
factors identifies the specific cell types susceptible to common brain diseases 
thus demonstrating how single cell chromatin accessibility data can be used for 
novel biological discoveries.
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CHAPTER 2:  CHARACTERIZATION OF CHROMATIN ACCESSIBILITY WITH 
A TRANSPOSOME HYPERSENSITIVE SITES SEQUENCING (THS-SEQ) 
ASSAY 
2.1 Introduction 
 DNase-seq and ATAC-seq have several inefficiencies that can be 
addressed to improve assay sensitivity. In order to address this, we develop a 
new transposome based method requiring new processing steps, optimized 
buffers and an engineered Tn5 that better captures accessible chromatin. We 
then validate THS-seq and perform a comparison with 500 cells of input material 
between THS-seq/Tn5059, THS-seq/EzTn5, ATAC-seq/Tn5059, and ATAC-
seq/EzTn5 using the commonly used GM12878 lymphoblastoid cell line. Lastly 
we employ optimizations made in THS-seq to improve sensitivity in ATAC-seq.  
2.2 Results 
2.2.1 Experimental design and implementation 
We hypothesized that the limited sensitivity of ATAC-seq is inherent in the 
method design, and is mainly due to three factors. First the Tn5 transposome 
complex inserts adaptors in random orientation, such that only half of the 
molecules contain the adaptors in the orientation required for PCR amplification. 
Second, only ~1% of the genome is accessible in typical cells, and the regions in 
which two adjacent transposition events are too far apart cannot be amplified by 
PCR. In fact, for this reason, the existing DNase-Seq method includes a 
fragmentation step to capture and sequence only the flanking sequences 
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immediately adjacent to DNase I digestion sites, which effectively capture single-
digestion events. Third, accessible regions small in length would have too few 
transposition events, and in conjunction with losing half of the molecules due to 
incorrect adaptor orientation, would not produce enough molecules to form a 
detectible peak above background levels of transposition events. Therefore, 
applying such a fragmentation strategy to small numbers of cells or single cells 
would result in low sensitivity, especially in the small accessible regions. We 
therefore developed the THS-seq method, which uses a customized Tn5 
transposome system to attach a T7 promoter37-40 to the end of every DNA 
molecule after in vitro transposition. The end sequences of the insertion sites 
were then linearly amplified with in vitro transcription by roughly 1000-fold, 
regardless of the distance between two adjacent Tn5 insertion sites, and the 
resulting RNA molecules were then converted into sequencing libraries efficiently 
through seven enzymatic reactions (single-stranded cDNA synthesis, RNase H 
digestion, double-stranded cDNA synthesis, transposition, protease digestion, 
end fill-in and PCR amplification) (Fig 2.1) To this end we designed a custom 
transposon that, in addition to the mosaic end sequences for transposase 
binding, includes a T7 promoter sequence for in vitro transcription, and an 
adaptor sequence compatible with constructing Illumina sequencing libraries 
(Fig. 2.2). Additionally, to address the efficiency loss from incorrect adaptor 
orientations that is seen with PCR based methods, the transposome complex 
dimer that consists of two Tn5 molecules and two transposons, where one Tn5 
molecule is bound to one transposon, was designed and generated so that every  
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Figure 2.1. Schematic overview of THS-seq. 
High efficiency tagmentation is performed on gently lysed cells, followed by in 
vitro transcription, and custom RNA-seq to generate barcoded sequencing 
libraries. The following colors depict the following segments. Light gray 
segments are Tn5 mosaic ends sequences, green segments are T7 promoter 
sequences, dark red segments are read primer sequences, dark blue 
segments are genomic DNA, light blue segments are cDNA sequences, 
purple segments are 3’ adaptor sequences, orange and navy blue segments 
are Illumina adaptor sequences, and yellow circles are barcodes. 
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Figure 2.2. Schematic of transposon design and transposome complex 
generation.  
Transposon consists of the T7 promoter, Read primer sequence, and the 
mosaic end sequence for Tn5 binding that is contained within the read 
sequence. 
 
single insertion yields usable ends regardless of the orientation of the transposon 
after insertion. Successful insertion of our customized transposon was confirmed 
by electrophoresis (Fig. 2.3). Next, all proteins were removed by treatment with 
guanidine hydrochloride, followed by end fill-in and linear in vitro transcription 
amplification by T7 RNA polymerase which in theory has a lower bias 
(propagation of errors introduced early in PCR) compared with exponential PCR 
11 
 
 
amplification. The resulting RNA molecules (Fig. 2.4a-d) were converted to 
double stranded cDNA, followed by a second round of transposition to tag 3’-
ends of double stranded cDNA. Transposase was digested by protease to 
release DNA fragments and then to generate sequencing libraries, PCR 
amplification was performed that added sequence containing Illumina adaptors 
and a sample barcode (Fig. 2.5a-d). Multiple samples were tagged with sample-
specific DNA barcodes, pooled and size selected for Illumina sequencing. Finally, 
we replaced the standard EzTn5 transposase with a novel Tn5 super-mutant 
(Tn5059), which resulted from a semi-rational design and has a higher activity 
and less sequence-specific bias than EzTn5 on purified DNA. Concentration 
titrations were performed on Tn5059 for optimal activity for THS-seq with cellular 
input (Fig. 2.6a-d), as well as development of an optimized tagmentation reaction 
buffer that includes 16% DMF (Fig. 2.6e-f).  
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Figure 2.3. Validation of successful transposon insertion and DNA 
fragmentation. 
The first two lanes are reactions using 0.7 µM Tn5059, the third and fourth 
lanes are reactions containing 0.5 µM EzTn5, the fifth and sixth lanes have 
Tn5 replaced with nuclease free water, the seventh lane is a reaction with 0.7 
µM Tn5059 and with water substituted for DNA in the reaction, and the eighth 
lane is a reaction with 0.5 µM EzTn5 with water substituted for DNA in the 
reaction. The customized EzTn5 and Tn5059 transposomes are designed to 
fragment DNA upon transposon incorporation. By fragmenting DNA, this 
implies the mosaic end DNA oligo and transposon oligo anneal correctly, the 
transposome complex is forming correctly, the transposome complex is active, 
and the transposome complex can successfully fragment DNA and insert the 
transposon. Successful attachment of the transposon is indicated by 
generation of in vitro transcribed RNA, which is shown in Figure 2.4. It is not 
expected to have dark smears for fragmented DNA, since 6 nanograms of 
DNA were used as input and no PCR was done after fragmentation. 
Experimentally a transposition reaction was performed on samples, cleaned 
with zymo DNA clean and concentrator, and then run on a 6% Tris-borate-
EDTA (TBE) gel. 
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Figure 2.4. Validation of T7 in vitro transcription. 
6% Tris-Borate-Urea (TBU) gels assaying for single stranded nucleic acids, in 
this case RNA, are used for validation of RNA amplification from in vitro 
transcription. Generally, smears are seen from ~150 base pairs to >2000 base 
pairs. (a) RNA smears from THS-seq with Tn5059 using 100 cells, 1000 cells 
and 6 nanograms of pure DNA. No RNA smear is generated for the NTC 
control. (b) Quantitation of the in vitro transcribed RNA smears present in (a). 
(c) RNA smears are also present for assaying with both 500-cell THS-seq with 
Tn5059 and 500-cell THS-seq with Ez-Tn5 and 6 nanograms of pure DNA 
with each respective enzyme. No RNA smears are generated for the NTC 
controls for each respective enzyme. (d) Quantitation of the in vitro transcribed 
RNA smears present in (c). 
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Figure 2.5. Validation of PCR amplification for barcode addition. 
6% TBE gels for assaying double stranded DNA are used here for confirming 
generation of barcoded libraries. (a) Libraries have been successfully 
generated for THS-seq with Tn5059 using 100 cells, 1000 cells and with 6 
nanograms of pure DNA. No DNA smears are generated for the NTC control. 
(b) Quantitation of size selected library smears present in (a). (c) DNA smears 
are also present for assaying with both 500-cell THS-seq with Tn5059 and 
500-cell THS-seq with Ez-Tn5 and 6 nanograms of pure DNA with each 
respective enzyme. No DNA smears are generated for the NTC controls for 
each respective enzyme. (d) Quantitation of size selected library smears 
present in (c). Subsequently libraries are pooled, and gel size selected 
between ~220-250 to ~1000 base pairs to remove primers and primer dimers 
below the 220-250 base pair range. 
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Figure 2.6. Tn5059 concentration titrations and titration of 
dimethylformamide concentrations for optimal in vitro transcription 
amplification yields. 
(a-d) Concentration titrations were performed to determine the optimal 
concentration of Tn5059 for assaying accessible chromatin on 1000 
GM12878 lymphoblastoid cells that gives the most in vitro transcription 
amplification product. 6% TBU gels were used for visualization. (a,b) 
Concentration titration of Tn5059 was performed at a range of 3.5 μM to 0.2 
μM Tn5059 final concentration in reaction. Here 0.9 μM Tn5059 gave the 
best amplification and the reaction with 3.5 μM Tn5059 was similar, however 
the smear looks washed out and not how IVT smears usually appear, also 
with 0.9 μM Tn5059 reagents are saved. The 1.8 μM Tn5059 reaction 
possibly had pipetting errors. (c,d) The concentration titration of Tn5059 was 
performed with 0.7 μM to 0.1 μM Tn5059 final in reaction, and here 0.7 μM 
gave the strongest amplification. The quantitation of IVT RNA differs greatly 
between the gels since differences in how the ladders ran affected 
quantitation, however the trends are similar. We also performed a titration on 
DMF to determine the optimal concentration for tagmentation that gives the 
most in vitro transcription amplification product. Reactions used 1000 
GM12878 lymphoblastoid cells. Titration was performed on a transposon that 
was 17 base pairs longer than the one used in the study, T7tspn-top2, 
however the result of this titration should be applicable to any transposon that 
is being used to assay accessible chromatin. The concentration of other 
tagmentation reaction buffer components that was kept consistent while DMF 
concentrations were varied was, 165 mM Tris-OAc, pH 7.8, 330 mM K-OAc, 
50 mM Mg-OAc. All reactions were carried out in 5 μL solutions. (e) First a 
wider range of DMF concentrations were titrated, and once an optimal 
concentration was determined, (f) a narrower range was titrated to confirm 
the results. 
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2.2.2 THS-seq validation 
To validate THS-Seq, we applied the method to 100 GM12878 
lymphoblastoid cells, and generated 71.5 and 83.4 million Illumina sequencing 
reads per replicate. After sequence alignment and clonal read removal, we 
obtained roughly 11 million uniquely mapped reads for each library. Each THS-
seq unique read by design represents a unique transposon insertion event on a 
single chromosomal molecule. Therefore, ~110,000 unique transposition events 
per cell was captured in our data set. We then performed peak calling with 
Dfilter41, and observed consistency in the base pair overlap called between the 
two technical replicates (Fig. 2.7b-c). Chromatin accessibility profiles mimicked 
published ENCODE DNase I data of GM12878 (Fig. 2.7a). In comparison with 
ENCODE reference data there was 61% base pair overlap with Duke data, and 
70% overlap with UW data from the same cell line42, and this was comparable to 
base pair overlap between the ENCODE datasets from different labs when 
overlapped against each other (Fig. 2.7d, Table 1). Additionally, base pair 
overlap between published 50,000-cell ATAC-seq data and 100-cell THS-
seq/Tn5059 data was 61%, which is comparable to ENCODE data base pair 
overlaps against themselves as well as the number of peaks called and peak 
size distributions from published 50,000-cell ATAC-seq data, indicating a ~500-
fold improvement of sensitivity (Fig. 2.7d, e-f, Table 2). This increase in 
sensitivity is accompanied by a 30% increase in the total base pairs called 
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significant by 100-cell THS-seq/Tn5059 over published 50,000-cell ATAC-seq 
data (Table 3). In contrast, the control data generated from 6 nanograms of 
purified genomic DNA, where all proteins have been removed and DNA is 
completely open, yielded mostly non-specific peaks that have less than 1% 
overlap with ENCODE datasets (Fig. 2.7a, Table 1). Furthermore, an analysis by 
GREAT43 shows accessible regions form a bimodal distribution of peaks around 
transcription start sites, suggesting that accessible regions largely lie over 
regulatory non-coding regions (Fig. 2.8a). Annotation of accessible regions 
identified enrichment of immune system and B lymphocyte biological processes, 
including interferon signaling, B cell receptor signaling pathway, and B cell 
homeostasis, which are known to be upregulated in EBV transformed 
lymphoblastoid cells44-46 (Fig. 2.9). There is a well-known limitation with ATAC-
seq where 30-50% of sequenced reads are clonal reads from the mitochondrial 
genome, however with 100-cell THS-seq/Tn5059, only 6% of mapped reads 
came from the mitochondrial genome (Fig. 2.10a-c).  
  
18 
 
 
 
 
Figure 2.7. Validation of 100-cell THS-seq/Tn5059 data against ENCODE data 
and ATAC-seq data. 
(a) 200 kb view of accessible chromatin marks in GM12878 lymphoblastoid cells in 
100-cell THS-seq/Tn5059 data, a purified DNA control, published ENCODE 
accessibility data from Duke and UW, and ENCODE histone modifications which 
are often found near regulatory elements and promoters. (b) Correlation of 100-cell 
THS-seq/Tn5059 replicate one data and 100-cell THS-seq/Tn5059 replicate two 
data. (c) Base pair overlap of 100-cell THS-seq/Tn5059 replicate one data and 
100-cell THS-seq/Tn5059 replicate two data. (d) Base pair overlap between 100-
cell THS-seq/Tn5059 replicate two data and ENCODE datasets, and ENCODE 
datasets base pair overlap amongst themselves. 100-cell THS-seq/Tn5059 
replicate two data was used in ENCODE comparisons because it had the most 
base pairs in peaks called significant. (e) Peak size distributions between 100-cell 
THS-seq/Tn5059 datasets, and published 50,000-cell ATAC-seq datasets. (f) Base 
pair overlap between 100-cell THS-seq/Tn5059 and published 50,000-cell ATAC-
seq replicate 4 data. Published 50,000-cell ATAC-seq replicate 4 data was used 
since it had the most base pairs called significant compared to the other published 
50,000-cell ATAC-seq datasets. 
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Figure 2.8. Comparison of peak region distances to transcription start 
sites. 
For peak calling all samples were down sampled to 8,351,125 unique reads. 
Peak files generated by Dfilter were inputted into GREAT for analysis. Peak 
regions that caused database errors were removed, which was usually one to 
ten peaks per file, and thus should not impact the analysis. The replicate 
represented in each analysis was chosen based on if they had more base 
pairs called significant, and more base pair overlap with ENCODE data. 
Datasets represented are: (a) 100-cell THS-seq with Tn5059 Rep2, (b) 500-
cell THS-seq with Tn5059 Rep1, (c) 500-cell THS-seq with EzTn5 Rep1, (d) 
500-cell ATAC-seq with Tn5059 Rep2, (e) 500-cell ATAC-seq with EzTn5 
Rep2. 
 
20 
 
 
Figure 2.9. Significant gene ontology biological processes categories for 
each peaks dataset. 
This is part of the same analysis performed by GREAT that was used in Figure 
2.8, and thus the same peaks files are used as input. The replicate represented 
was chosen based on if they had more base pairs called significant, and more 
base pair overlap with ENCODE data. Datasets represented are: (a) 100-cell 
THS-seq with Tn5059 Rep2, (b) 500-cell THS-seq with Tn5059 Rep1, (c) 500-
cell THS-seq with EzTn5 Rep1, (d) 500-cell ATAC-seq with Tn5059 Rep2, (e) 
500-cell ATAC-seq with EzTn5 Rep2. 
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Figure 2.10. Quantitation of mitochondrial reads in all datasets 
The number of mitochondrial reads (chrM) were counted and represented as 
a percentage of (a) the total number of clonal reads, and (b) the total number 
of mapped reads in each dataset. (c) In 100-cell THS-seq with Tn5059, the 
proportion of clonal reads from each chromosome was calculated as a 
percentage of the total clonal reads for each sample. 
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2.2.3 Comparison of THS-seq and ATAC-seq with two transposases: Tn5059 
and EzTn5 
We next sought to identify the contributions to the improved sensitivity by 
individual components of THS-seq. More specifically, we asked whether a direct 
replacement of the transposase in ATAC-seq, which had fewer processing steps, 
would lead to a similar level of improvement, and whether Tn5059 led to a 
substantial improvement over EzTn5 with the THS-seq protocol. We used an 
input of 500 cells in order to directly compare with published 500-cell ATAC-seq 
data5. We performed ATAC-seq and THS-seq with EzTn5 and Tn5059, 
generating data for all four combinations in two replicates. To eliminate the 
effects of variable read depth among different data sets, we down-sampled all 
data sets to 8,351,125 uniquely aligned reads per sample, which matched the 
sample with the lowest number of unique alignments, and was adequate for 
generating accessibility data metrics (Fig. 2.11, Table 3, Table 4). Technical 
replicates consistently have high base pair overlap, peak overlap and 
correlations with each other (Fig. 2.12a, Fig. 2.13a, 2.14a). 500-cell THS-
seq/Tn5059 consistently performs the best by generating 61% more significant 
peaks, calling 54% more base pairs significant, having 45% more peak overlap 
with ENCODE UW peaks, having 16% more peak overlap with ENCODE Duke 
peaks, and having 30% more base pairs overlapped with UW base pairs, when 
compared with 500-cell ATAC-seq/EzTn5 data, which is the next most 
comprehensive accessibility dataset (Fig. 2.12b-d, Fig. 2.13b-c, Fig. 2.14b,  
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Figure 2.11. 100-cell THS-seq with Tn5059 read statistics analysis to 
determine minimal number of raw reads for quality data. 
Raw reads were down sampled in increments of 10 million reads with in house 
scripts, run through BWA with default parameters, and then were run through 
Dfilter to (a) call peaks, (b) determine total number of base pairs called 
significant, (c) calculate ENCODE data overlap, and (d) determine the total 
number of unique and clonal reads. The mean and standard deviation 
between the two 100-cell THS-seq with Tn5059 replicates was calculated and 
displayed. 
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Figure 2.12. Comparison between THS-seq/Tn5059, THS-seq/EzTn5, 
ATAC-seq/Tn5059, and ATAC-seq/EzTn5 with 500 cells of input material. 
All datasets and replicates were down sampled to 8,351,125 unique 
alignments before analysis. (a) Correlation between replicates for each 
experimental condition. (b) Base pair overlap of each experimental condition 
with UW data. The replicate with the most base pairs called significant was 
used in analysis and represented in each condition. UW data was chosen 
since it had the most base pairs called significant of the ENCODE datasets. 
(c) Total number of peaks called by Dfilter for each condition. (d) Total number 
of base pairs under peaks called significant by Dfilter 
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Figure 2.13. Peak overlap comparisons in all datasets.  
Peaks were counted as overlapped if at least one base pair is overlapped in 
two significant peaks that are overlapped against each other in the datasets 
being compared. All samples except ENCODE Duke and UW samples were 
down sampled to the same number of unique reads, 8,351,125, before peak 
calling. (a) Peak overlap for all experimental replicates when overlapped 
against each other. (b) Peak overlap for the experimental replicate with the 
most base pairs called significant against ENCODE Duke data. (c) Peak 
overlap for the experimental replicate with the most base pairs called 
significant against ENCODE UW data. (d) Peak overlap for the experimental 
replicate with the most base pairs called significant against published 50,000-
cell ATAC-seq replicate 4 data. (e) Peak overlap of ENCODE UW and Duke 
data against themselves, and ENCODE UW and Duke data against published 
50,000-cell ATAC-seq replicate 4 data. 
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Figure 2.14. Base pair overlap comparisons in all datasets.  
If a base pair that is within a significant peak is overlapped with the same base 
pair in a significant peak in the dataset being compared to, then it is called 
significant and counted. All samples except ENCODE Duke samples were down 
sampled to the same number of unique reads, 8,351,125, before peak calling. 
(a) Base pair overlap for all experimental replicates when overlapped against 
each other. (b) Base pair overlap for the experimental replicate with the most 
base pairs called significant against ENCODE Duke data. (c) Base pair overlap 
for the experimental replicate with the most base pairs called significant against 
published 50,000-cell ATAC-seq replicate 4 data. (d) Base pair overlap of the 
two most comprehensive published 50,000-cell ATAC-seq datasets, replicate 3 
and replicate 4. 
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Table 3). Peak overlaps are comparable to ENCODE and published 50,000 
ATAC-seq data overlap amongst themselves (Fig. 2.13e). Pairwise comparisons 
of peak overlap and base pair overlap between all four combinations show that 
THS-seq or ATAC-seq against each other, regardless of enzyme used, have the 
best overlap (Fig. 2.15, Fig. 2.16). The two most comprehensive datasets, 500-
cell THS-seq/Tn5059 and 500-cell ATAC-seq/EzTn5 when overlapped against 
each other have 62% of the same peaks covered, and 50% of the same base 
pairs covered, of the total from the 500-cell ATAC/EzTn5 dataset (Fig. 2.15, Fig. 
2.16). Interestingly 500-cell ATAC-seq/EzTn5 has 7.7% more base pair overlap 
with Duke data than 500-cell THS-seq/Tn5059, possibly because 500-cell ATAC-
seq/EzTn5 data captures larger portions of peaks, where THS-seq instead 
captures individual peaks in the same region that are smaller (Fig. 2.13b, Fig. 
2.14b). This can be explained by the increased sensitivity of THS-seq/Tn5059, 
which in this case would result in less base pair coverage and more overlapping 
peaks called. It could also be that the Duke data was generated differently due to 
protocol differences, and is capturing larger peaks6. Compared with published 
50,000-cell ATAC-seq data, 500-cell THS-seq/Tn5059 has 49% more peak 
overlaps and 16% more base pair overlaps than 500-cell ATAC-seq/EzTn5. 500-
cell THS-seq/Tn5059 data also has more comparable peak overlap of 36,846 
peaks to published 50,000-cell ATAC-seq data and Duke data peak overlap of 
30,417 peaks, and 50,000-cell ATAC-seq and UW data peak overlap of 35,501 
peaks. 500-cell ATAC-seq/EzTn5 peak overlap with 50,000-cell published ATAC-
seq data is comparably less than ENCODE datasets overlap with 50,000-cell 
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published ATAC-seq data, with 19% less Duke data peak overlap, and 30% less 
UW data overlap, with 24,759 peaks. (Fig. 2.13d-e, Fig. 2.14c). A higher fraction 
of overlapping peaks and base pairs between THS-seq and ENCODE reference 
data indicates that THS-seq not only has a higher sensitivity, but also a higher 
specificity, which could be due to either less sequence-specific bias or less off-
target transposition or both. 
THS-seq with EzTn5 provides an obvious improvement for all metrics over 
the published ATAC-seq data from 500 cells5. Compared with the 500-cell data 
we generated in this study using ATAC-seq/EzTn5 in our optimized protocol, 
THS-seq/EzTn5 identified 25% more peaks that are smaller in size, such that 
6.7% less base pairs were covered (Fig. 2.12b-d, Table 3). Unexpectedly, 
ATAC-seq/Tn5059 results in the least number of peaks called, base pairs called 
significant and base pair overlap with ENCODE reference data (Fig. 2.12b-d, 
Table 3). This is also reflected in the gene ontology analysis by GREAT43, which 
reported ontology categories mostly not involved with immune system function 
for ATAC-seq/Tn5059 peaks (Fig. 2.9d). Furthermore, the data is reflected when 
visually inspecting the data tracts, where THS-seq/Tn5059, and ATAC-
seq/EzTn5 have the most well defined peaks (Fig. 2.17). 
THS-seq and ATAC-seq, regardless of which enzyme was used, identified 
similar number of peaks, 5,098-7,310, within 5 kilobases of transcription start 
sites. However, THS-seq called 1.5 to two times more peaks in distal regions to 
transcription start sites, suggesting additional regulatory regions are being 
captured by THS-seq that are not being captured with ATAC-seq (Fig. 2.18e). 
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This leads to gene ontology descriptions that appear more descriptive of 
GM12878 lymphoblastoids, such as the B cell receptor signaling pathway, and B 
cell homeostasis (Fig. 2.8, Fig. 2.9). Further inspection of these gene 
enrichments reveals genes where 100- and 500-cell THS-seq/Tn5059 was able 
to identify accessible regions, and 500-cell ATAC-seq/EzTn5 did not. Some 
notable examples include ABCA12, FCRL4, IFI44, PDGFD, and PHLDB2 (Fig. 
2.19a-e). Genes including BCL2, CASP3, CD38, the interferon gene cluster and 
specifically IFNA2, and MAPK1 that have major roles in cancer and in immune 
system function were enriched by both 100- and 500-cell THS-seq/Tn5059 and 
500-cell ATAC-seq/EzTn5, however 100- and 500-cell THS-seq/Tn5059 called 
two to six times as many peaks per gene region, and more accurately mirrored 
UW DNase-seq data from the same gene regions (Fig. 2.20a-e). Consistent with 
published results, ATAC-seq/EzTn5 mitochondrial reads account for more than 
30% of the total reads, and account for three times the percentage of mapped 
reads when compared to THS-seq. ATAC-seq/Tn5059 mitochondrial read 
percentages are similar to THS-seq, probably due to the difference of sequence 
preference between EzTn5 and Tn5059 (Fig. 2.10a-b). 
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Figure 2.15. Examination of peak overlap in a pairwise comparison of all 
experimental datasets. 
 Peaks were counted as overlapped if at least one base pair is overlapped in 
two significant peaks that are overlapped against each other, in the datasets 
being compared. All samples were down sampled to the same number of 
unique reads, 8,351,125, before peak calling. 
 
  
31 
 
 
Figure 2.16. Examination of base pair overlap in a pairwise comparison 
of all experimental datasets.  
If a base pair that is within a significant peak is overlapped with the same 
base pair in a significant peak in the dataset being compared to, then it is 
called significant and counted. All samples were down sampled to the same 
number of unique reads, 8,351,125, before peak calling. 
 
 
  
32 
 
 
Figure 2.17. 200 kb view of accessible chromatin marks in 500 cell 
datasets. 
Comparison between THS-seq with Tn5059, THS-seq with EzTn5, ATAC-seq 
with Tn5059, and ATAC-seq with EzTn5 against ENCODE GM12878 
lymphoblastoid cell chromatin accessibility data from Duke and UW, and 
against histone modifications which are often found near regulatory elements 
and promoters. All samples were down sampled to the same number of 
unique reads, 8,351,125, before viewing tracts. 
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Figure 2.18. Comparison between the two most comprehensive datasets 
of 500-cell THS-seq/Tn5059 and 500-cell ATAC-seq/EzTn5. 
(a) Venn diagram depicting peak overlap between 500-cell THS-seq/Tn5059, 500-cell 
ATAC-seq/EzTn5 and ENCODE UW data. A peak is shared if one base pair or more 
overlaps with a peak in the dataset being compared to. (b) Venn diagram depicting 
peak overlap between 500-cell THS-seq/Tn5059, 500-cell ATAC-seq/EzTn5 and 
ENCODE Duke data. A peak is shared if one base pair or more overlaps with a peak 
in the dataset being compared to. (c) Representation of the number of peaks that are 
shared between all three datasets for UW data, peaks that are found by 500-cell THS-
seq/Tn5059 data and ENCODE UW data and not 500-cell ATAC-seq/EzTn5 data, and 
peaks that are found by 500-cell ATAC-seq/EzTn5 data and ENCODE UW data and 
not 500-cell THS-seq/Tn5059 data. Also a representation of the number of peaks that 
are shared between all three datasets for Duke data, peak regions that are found by 
500-cell THS-seq/Tn5059 data and ENCODE Duke data and not 500-cell ATAC-
seq/EzTn5 data, and peaks that are found by 500-cell ATAC-seq/EzTn5 data and 
ENCODE Duke data and not 500-cell THS-seq/Tn5059 data. (d) Comparison of peak 
size distributions. (e) Peak distances from transcription start sites as determined by 
GREAT43. 
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Figure 2.19. Overview of chromatin accessibility at gene loci enriched in 
100- and 500-cell THS-seq with Tn5059 data and not enriched in 500-cell 
ATAC-seq with EzTn5 data.  
Enriched genes from GREAT were used to determine which genes were enriched in 
THS-seq and not ATAC-seq. 100- and 500-cell THS-seq with Tn5059 and 500-cell 
ATAC-seq with EzTn5 were down sampled to the same number of unique reads, 
8,351,125, before analysis. UW DNase chromatin accessibility data was used for 
comparison since it was the most comprehensive of the GM12878 ENCODE datasets. 
ENCODE histone modifications which are often found near regulatory elements and 
promoters are also depicted. The replicate with the highest number of base pairs 
called significant was used in the read density data tract for each sample and for 
analysis. Also under each tract, the regions called significant by Dfilter are represented 
by bars. The gene loci for (a) ABCA12, (b) FRCL4, (c) IFI44, (d) PDGFD, and (e) 
PHLDB2 are represented.
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Figure 2.20. Overview of chromatin accessibility at major genes 
implicated in cancer and in immune system function.  
100- and 500-cell THS-seq with Tn5059 data and 500-cell ATAC-seq with 
EzTn5 data were down sampled to the same number of unique reads, 
8,351,125, before analysis. UW DNase chromatin accessibility data was used 
for comparison since it was the most comprehensive of the GM12878 
ENCODE datasets. ENCODE histone modifications which are often found near 
regulatory elements and promoters are also depicted. The replicate with the 
highest number of base pairs called significant was used in the read density 
data tract for each sample and for analysis. Also under each tract, the regions 
called significant by Dfilter are represented by bars. The gene loci for (a) BCL2, 
(b) CASP3, (c) CD38, (d) the interferon gene cluster and specifically IFNA2, 
and (e) MAPK1 are represented. Enrichments performed by GREAT reported 
BCL2, CD38 and MAPK1 in the B cell receptor signaling pathway gene 
ontology biological process category. BCL2, CD38 and MAPK1 were reported 
for the B cell homeostasis gene ontology biological process category. IFNA2, 
IFNA1, IFNA5, IFNA6 and IFNA8 were reported for the response to type I 
interferon gene ontology biological process category. 
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2.2.4 Comparison of THS-seq/Tn5059 and ATAC-seq/EzTn5 
We next sought to further characterize and directly compare the two most 
comprehensive datasets of 500-cell THS-seq/Tn5059 and 500-cell ATAC-
seq/EzTn5. In order to determine the number of peaks that were found unique 
between ENCODE UW data and 500-cell THS-Seq/Tn5059 data, and not found 
by 500-cell ATAC-seq/EzTn5 data, a union dataset was made. Here we found 
500-cell THS-seq/Tn5059, 500-cell ATAC-seq/EzTn5 and UW had 22,700 peaks 
in common, while 500-cell THS-seq/Tn5059 data had 240% more uniquely 
identified peaks that overlap with UW data than 500-cell ATAC-seq/EzTn5 data 
(Fig. 2.18a-c). The same analysis was performed with Duke data, though 9.3% 
less peaks were found in common between all datasets, and 500-cell THS-
seq/Tn5059 had 68% more uniquely identified peaks that overlap with Duke data 
than 500-cell ATAC-seq/EzTn5 data (Fig. 2.18b-c). Next, we examined the 
distribution of peak sizes for each dataset, and found peaks in the smaller size 
range of 100–1200 base pairs and larger size range of 1300-3000 base pairs, 
relative to 500-cell ATAC-seq/EzTn5, are gained with 500-cell THS-seq/Tn5059 
(Fig. 2.18d, Table 2). These peaks are present in more proximal and distal 
regions from the transcription start site, suggesting involvement in regulatory 
regions (Fig. 2.18e). The best published 50,000-cell ATAC-seq data sets 
approach the capture rate of smaller peaks by THS-seq/Tn5059, suggesting 
higher sensitivity Tn5 based methods are able to capture these peaks (Fig. 
2.21f-g). 
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We next sought to confirm that these extra peaks 100-1200 base pairs in 
length are not artifact generated by THS-seq, but instead has biological 
significance. A possibility is that these smaller peaks overlap in portions of larger 
peaks in 500-cell ATAC-seq/EzTn5 data, and thus are being counted as parts of 
single large peaks, or could be a unique set of called peaks. To investigate this, 
we examined the total base pair overlap with ENCODE Duke and UW DNase-
Seq data for each individual peak length. Since 75% and 125% more peaks in 
the size range of 100-1200 base pairs and 1700-3000 base pairs respectively are 
identified by 500-cell THS-seq/Tn5059 (Fig. 2.18d), we would expect a marked 
increase in the number of significant base pairs that overlap with ENCODE data 
at these peak lengths. Indeed with ENCODE UW data as the reference we 
observed an increase in overlapping base pairs in peaks 100-1200 base pairs 
and 1700-3000 base pairs (Fig. 2.22a), suggesting the additional small peaks 
detected by THS-seq are also present in ENCOCE UW data. However, when 
examining the Duke data, we found no difference among all three data sets in 
overlapping base pairs with peaks 100-1200 base pairs, but more base pair 
overlap with THS-seq data and Duke data in the range of 1700-3000 base pairs 
(Fig. 2.22b). Therefore, there is a difference in the peaks called by the two 
ENCODE data sets (Duke versus UW) that needs to be taken into account during 
analysis. Interestingly, the spike in base pair overlap seen from 1300-1600 base 
pairs in 500-cell ATAC-seq/EzTn5 data is due to both ATAC-seq/EzTn5 and 
ENCODE Duke and UW data better capturing peaks in the 1300-1600 base pair 
size range (Fig. 2.22a-b, Fig. 2.21a-b, e). Moreover, to further validate the  
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Figure 2.21. Peak size distribution comparisons between THS-seq, ATAC-
seq and ENCODE data.  
ENCODE data from Duke and UW for chromatin accessibility on GM12878 
lymphoblastoid cells was processed as described in methods. All THS-seq and 
ATAC-seq datasets were down sampled to the same number of unique reads, 
8,351,125, before analysis, except for 100-cell THS-seq with Tn5059 datasets, 
and the published 500-cell ATAC-seq replicate two dataset, which had less 
than 8,351,125 unique reads. For all datasets, counts of the number of peaks 
for each peak size were performed in 100 base pair increments, using the 
peaks file generated by Dfilter. Some data points were excluded from the 
graphs because values were beyond the axis, and the number of data points 
excluded for each graph is: (a) 14, (b) 8, (c) 8, (d) 8, (e) 8, (f) none, (g) 8, (h) 
11. Samples compared to ENCODE data include: (a) 100-cell THS-seq with 
Tn5059, (b) 500-cell THS-seq with Tn5059, (c) 500-cell THS-seq with EzTn5, 
(d) 500-cell ATAC-seq with Tn5059, (e) 500-cell ATAC-seq with EzTn5, (g) 
Published 50,000-cell ATAC-seq data, and (h) published 500-cell ATAC-seq 
data. (f) A peaks distribution comparison of 500-cell THS-seq with Tn5059 was 
also done against published 50,000-cell ATAC-seq data. 
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Figure 2.22. Validation of peaks based on peak length. 
(a) Base pair overlap with ENCODE UW data based on peak lengths for 100-
cell and 500-cell THS-seq/Tn5059 data, and 500-cell ATAC-seq/EzTn5 data. 
(b) Base pair overlap with ENCODE Duke data based on peak lengths for 100-
cell and 500-cell THS-seq/Tn5059 data, and 500-cell ATAC-seq/EzTn5 data. 
(c) The percentage more peaks found in 100-cell and 500-cell THS-
seq/Tn5059 than in 500-cell ATAC-seq/EzTn5 data, and the percentage more 
normalized 100-cell and 500-cell THS-seq/Tn5059 and UW base pair overlap 
than in 500-cell ATAC-seq/EzTn5. Normalizing was performed using the global 
base pair overlap values for each ENCODE dataset. (d) Zoom in on graph (c) 
showing the peak lengths between 100-1200 base pairs. 
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extra peaks found with THS-seq/Tn5059, we examined the percentage more 
identified peaks than 500-cell ATAC-seq/EzTn5, and the normalized THS-
seq/Tn5059 and ENCODE UW overlap. We would expect that when we see 60-
80% more peaks called in 500-cell THS-seq/Tn5059 than ATAC-seq/EzTn5, we 
would see 40% less base pairs overlap, which is what is actually seen for peaks 
100-1200 base pairs in length (Fig. 2.23a-b). Global ENCODE UW overlap is 
60% for 500-cell THS-seq/Tn5059 data, and 70% for 100-cell THS-seq/Tn5059 
data. Normalizing THS-seq/Tn5059 and UW base pair overlap with those values 
shows the extra peaks called by THS-seq/Tn5059 in the 100-1200 base pair size 
range overlap at the expected percentages. (Fig. 2.22c-d). Additionally, there are 
more normalized base pair overlaps with 100 base pair peaks and 1700-3000 
base pair peaks in 100- and 500-cell THS-seq/Tn5059, suggesting these peaks 
have higher base pair overlap then the average global ENCODE UW overlap 
percentage (Fig. 2.22c-d, Fig. 2.23a). This further suggests these THS-seq 
peaks represent true accessible regions, not artifacts.  
Interestingly the same results are not reflected with ENCODE Duke data 
when examining normalized THS-seq/Tn5059 and ENCODE Duke base pair 
overlaps, when normalized to ENCODE Duke global overlap of 61% for 100 cell 
data, and 49% for 500 cell data (Fig. 2.23c-f). The normalized overlap 
percentage is greatly below the percentage of peaks called, for peaks 100-1200 
base pairs in length, suggesting these peaks are not present in ENCODE Duke 
data. The exception is with normalized 500-cell THS-seq/Tn5059 ENCODE Duke 
base pair overlaps, where peaks 100-300 base pairs in length are above and 
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closely match the percentage more peaks, suggesting these additional peaks are 
also present in ENCODE Duke data (Fig. 2.23e-f). Interestingly there are 70% 
more normalized THS-seq/Tn5059 and ENCODE Duke base pair overlaps with 
100 base pair peaks, and more normalized base pair overlaps with peaks greater 
than 1700 base pairs, suggesting these peaks have higher base pair overlap with 
ENCODE Duke data than the average global overlap percentage (Fig. 2.23e-f). 
Overall, we see some differences between THS-seq data and ENCODE Duke 
data that are not seen between THS-seq and ENCODE UW data, which could be 
due to factors such as protocol differences, sample preparation or stochastic 
differences in the GM12878 cells assayed. 
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Figure 2.23. Validation of peaks based on peak length. 
(a) The percentage more peaks found in 100-cell and 500-cell THS-seq with 
Tn5059 data then in 500-cell ATAC-seq with EzTn5 data, and the percentage 
more 100-cell and 500-cell THS-seq with Tn5059 and UW base pair overlap 
then in 500-cell ATAC-seq with EzTn5. (b) Zoom in on graph (a) showing the 
peak lengths between 100-1200 base pairs. (c) The percentage more peaks 
found in 100-cell and 500-cell THS-seq with Tn5059 data then in 500-cell 
ATAC-seq with EzTn5 data, and the percentage more 100-cell and 500-cell 
THS-seq with Tn5059 and Duke base pair overlap then in 500-cell ATAC-seq 
with EzTn5. (d) Zoom in on graph (c) showing the peak lengths between 100-
1200 base pairs. (e) The percentage more peaks found in 100-cell and 500-cell 
THS-seq with Tn5059 data then in 500-cell ATAC-seq with EzTn5 data, and 
the percentage more normalized 100-cell and 500-cell THS-seq with Tn5059 
and Duke base pair overlap then in 500-cell ATAC-seq with EzTn5. 
Normalizing was performed using the global base pair overlap values for the 
ENCODE Duke dataset. (f) Zoom in on graph (e) showing the peak lengths 
between 100-1200 base pairs 
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2.2.5 Characterization of capture sensitivity and ATAC-seq bias 
We next investigated further the open chromatin regions, or peaks, called 
with the four combinations. Both THS-seq/Tn5059 and ATAC-seq/EzTn5 have 
high percentages of alignments in peaks, with 25% and 27% respectively. 
Replacement of EzTn5 with Tn5059 in THS-seq results in 2.0 to 2.8 times more 
unique alignments in peaks (Fig. 2.24a). From this it can be conjectured that 
Tn5059 has higher preference for areas of open chromatin and/or EzTn5 has a 
higher background sporadic transposition activity in more compact chromatin, 
which explains how THS-seq with EzTn5 has significantly more background 
noise. For ATAC-seq with EzTn5, this is actually beneficial when considering the 
areas directly adjacent to an accessible region are semi-accessible. EzTn5 would 
insert more into regions around an open region than would Tn5059 and would 
generate more PCR viable fragments. This then semi-compensates for the 50% 
sample loss from using ATAC-seq. Moreover, this explains how ATAC-seq with 
Tn5059 has the least number of unique alignments in peaks. Coupled with 
Tn5059’s more selective insertion properties, ATAC-seq’s inherent 50% sample 
loss upon transposition dilutes the number of alignments in any peaks by at least 
50%, and hinders capture of any smaller regions of open chromatin. This is 
reflected in peak size distributions, where both ATAC-seq/Tn5059 and THS-
seq/EzTn5, have 49% and 30% of peaks respectively in the size range of 100-
300 base pairs long, which is 2-3 times the number of peaks found in that size 
range for THS-seq/Tn5059 or ATAC-seq/EzTn5. (Fig. 2.21c-d, Fig. 2.25f, g, 
Table 2). We hypothesized that higher background transposition events with 
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THS-seq/EzTn5, and sample loss with ATAC-seq/Tn5059 raised the thresholds 
for calling significant peaks, thus resulting in only the most significant portions of 
peaks being called significant and leading to smaller peak sizes. Further 
evidence reinforcing this interpretation is seen when examining the number of 
unique alignments within significantly called peaks, where THS-seq/EzTn5 and 
ATAC-seq/Tn5059 have the lowest with 11% and 6.4% of unique alignments in 
peaks, respectively (Fig. 2.24a). Here, the percentage of alignments in peaks is 
indicative of peak capture efficiency. 
We next characterized peak capture bias in ATAC-seq, where 
preferentially peaks of longer length were captured, and peaks of shorter length 
were lost. ATAC-seq/EzTn5 had 20% more alignments in the larger 30% of 
peaks than did THS-seq/Tn5059, and concomitantly 27% less alignments in the 
smaller 70% of peaks respectively (Fig. 2.24b-c). Moreover, this is further 
illustrated as THS-seq/Tn5059 with both 100 and 500 cells of input material has 
an even distribution of normalized alignments over all peak lengths when 
compared to ATAC-seq/EzTn5, where normalized alignments increase as peak 
length increases beginning around a peak length of 1300 base pairs (Fig. 2.24d, 
Fig. 2.25a, b, d-e, h). The trend of more alignments in larger peaks is method 
consistent irrespective of enzyme used, and is seen in published 50,000-cell 
ATAC-seq data, though less so with published 500-cell ATAC-seq data due to 
sparse peak capture (Fig. 2.24b-f, Fig. 2.25a-c, Fig. 2.26a-b). We hypothesize 
the reason for THS-seq’s more uniform capture of accessible regions is due to 
method design, usage of Tn5059, and is a result of the length of amplified 
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molecules. The importance of fragment length in determining the type of 
biological data captured has been demonstrated with DNase-FLASH47, and with 
THS-seq the majority of fragments generated from in vitro transcription were 400-
2000+ base pairs, while the majority of fragments from PCR amplification with 
ATAC-seq were 200-800 base pairs (Fig. 2.4a, c). Additionally, with THS-seq, 
the downstream transposition step for addition of 3’ adaptors favors longer 
double stranded cDNA fragments. With longer fragment sizes and the hypothesis 
Tn5059 has higher preference for open chromatin, it is probable that THS-
seq/Tn5059 is losing sample due to insertions being too close to each other in 
accessible regions of longer length, which does not happen with ATAC-seq since 
PCR amplification favors smaller fragment sizes. This would lead to ATAC-seq’s 
preference for capturing larger accessible regions. However, this does not affect 
THS-seq peak capture, as this would only occur in large regions of accessible 
chromatin. It is possible to further modify the RNA processing method in THS-
seq to capture shorter fragments. Taken together, these data demonstrated that 
THS-seq/Tn5059 is feasible and improves upon current Tn5 based methods for 
measuring chromatin accessibility with limited inputs. This is achieved by 
reducing peak capture bias introduced by ATAC-seq, while providing data from 
100 cells comparable to DNase-seq on millions of cells, or ATAC-seq on 50,000 
cells. 
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Figure 2.24. THS-seq and ATAC-seq peak capture preferences and 
biases. 
All datasets and replicates were down sampled to 8,351,125 unique 
alignments before analysis. (a) Total percentage of unique alignments in peaks 
out of the 8,351,125 unique alignments for each dataset. (b) The percentage of 
alignments that are in the larger 30% of peaks called significant for each 
individual sample and replicate. (c) The percentage of alignments that are in 
the smaller 70% of peaks called significant for each individual sample and 
replicate. (d-f) For all peaks in each individual dataset, the normalized number 
of alignments in each peak length, with peak lengths in increments of 100 base 
pairs, represented by mean ± SEM in (d) 100-cell THS-seq/Tn5059 data and 
500-cell ATAC-seq/EzTn5 data, (e) 500-cell THS-seq/EzTn5 data and 500-cell 
ATAC-seq/Tn5059 data, and (f) 100-cell THS-seq/Tn5059 data and published 
50,000-cell ATAC-seq data. Some data points were excluded from the graphs 
because values were beyond the axis, and the number of data points excluded 
for each graph is: (d) 13, (e) 16, and (f) 8. 
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Figure 2.25. THS-seq and ATAC-seq peak capture preferences. 
All datasets were down sampled to 8,351,125 unique reads before analysis. 
Normalization was performed by calculating the number of reads per 100 
base pairs in each peak, and any peaks with zero alignments were removed 
before analysis. (a-c) For all peaks in each individual dataset, the normalized 
number of alignments in each peak represented by mean ± SEM in (a) 500-
cell THS-seq with Tn5059 and 500-cell ATAC-seq with EzTn5 (b) 100-cell 
and 500-cell THS-seq with Tn5059 (c) 100-cell THS-seq with Tn5059 and 
published 500-cell ATAC-seq data. Some data points were excluded from the 
graphs because values were beyond the axis, and the number of data points 
excluded for each graph is: (a) 13, (b) 4, and (c) 15. (d-h) For all peaks in 
each individual dataset, the normalized number of unique alignments in each 
peak, visualized from highest peak length to lowest, and with the most to the 
least number of normalized unique alignments for each peak length from left 
to right. Datasets represented had the most base pairs called significant by 
Dfilter of the two replicates for each condition. Datasets include (d) 100-cell 
THS-seq with Tn5059 Rep2, (e) 500-cell THS-seq with Tn5059 Rep1, (f) 500-
cell THS-seq with EzTn5 Rep1, (g) 500-cell ATAC-seq with Tn5059 Rep2, 
and (h) 500-cell ATAC-seq with EzTn5 Rep2. 
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Figure 2.26. Comparison of 500-cell ATAC-seq with EzTn5 data to 
published ATAC-seq data.  
A modified protocol that included an optimized tagmentation buffer and 
protease digestion of proteins and transposase were used for generating 500-
cell ATAC-seq with EzTn5 data, which was then compared to published 
50,000-cell ATAC-seq data, and published 500-cell ATAC-seq data. All 
samples were down sampled to the same number of unique reads, 8,351,125, 
before analysis. The replicate with the highest number of base pairs called 
significant was used in the venn diagram representations for each sample and 
in analysis. Comparisons were made examining (a) the total number of peaks 
called, (b) total number of base pairs called significant, (c) base pair overlap of 
published 50,000-cell ATAC-seq data, 500-cell ATAC-seq with EzTn5 data and 
published 500-cell ATAC-seq data against ENCODE accessibility data from 
UW and (d) base pair overlap of published 50,000-cell ATAC-seq data, 500-
cell ATAC-seq with EzTn5 data and published 500-cell ATAC-seq data against 
ENCODE accessibility data from Duke. 
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2.2.6 ATAC-seq improvements  
 Through optimizations to THS-seq, we inadvertently have made 
substantial improvements to ATAC-seq/EzTn5. Published 500-cell ATAC-seq 
data had on average 69% less peaks called, 70% less total base pairs called 
significant, and 61%-64% less ENCODE base pair overlap compared with 
published 50,000-cell ATAC-seq data (Fig. 2.26a-d Table 3). Upon examination 
of peak size distributions, published 500-cell ATAC-seq data replicate two had 
78% of all peaks in the 100-300 base pair range, thus indicating high background 
noise, while replicate one had 17,331 peaks called (Fig. 2.21h, Table 2, Table 
3). When we performed ATAC-seq/EzTn5, two changes were made to the 
published protocol. First, the tagmentation reaction contained 16% DMF as final 
concentration in reaction, and second, after tagmentation protease digestion was 
performed on tagmented DNA and any cellular proteins in solution. These 
changes were able to generate data from 500 cells that had 131% more peaks 
called, 169% more base pairs called significant, and 141% more ENCODE data 
base pair overlap than published 500-cell ATAC-seq data. This in turn generates 
data of higher quality, identifying more discernable chromatin accessibility peaks 
than published 500-cell ATAC-seq data (Fig. 2.21e, g, h, Fig. 2.27). For 500 
cells, our optimized ATAC-seq protocol with EzTn5 produced data at a quality 
approaching that of published 50,000-cell ATAC-seq data, albeit with 28% less 
peaks called, 20% less base pairs called significant, and 5-14% less ENCODE 
base pair overlap (Fig. 2.26a-d, Table 3). Together these data illustrate how 
minor optimizations in protocol can substantially improve ATAC-seq for 
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assessing chromatin accessibility, however still to a lesser degree than THS-
seq/Tn5059. 
 
Figure 2.27. 200 kb view of accessible chromatin in ATAC-seq with EzTn5 
data versus published ATAC-seq data. 
500-cell ATAC-seq with EzTn5 data was compared to published 50,000-cell 
ATAC-seq data, and published 500-cell ATAC-seq data. 500-cell ATAC-seq 
with EzTn5 data was generated using modified protocols with optimized 
tagmentation buffer and protease digestion of proteins and transposase. 
ENCODE accessibility data and histone modifications which are often found 
near regulatory elements and promoters are also depicted. All samples were 
down sampled to the same number of unique reads, 8,351,125, before viewing 
tracts 
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2.3 Discussion 
 In summary, THS-seq achieves a high sensitivity and specificity in 
detecting accessible chromatin by efficient in vitro transposition with a 
customized transposon, an optimized tagmentation buffer and an engineered 
Tn5 super-mutant, as well as linear RNA amplification of tagmented DNA 
molecules. We have validated THS-seq/Tn5059 against ENCODE data, and 
have shown it captures many peaks ATAC-seq/EzTn5 does not, including a large 
number of smaller peaks with probable roles in more proximal and distal 
regulatory regions to transcription start sites. The superior performance of THS-
seq with Tn5059 over ATAC-seq with either enzymes, or THS-seq with EzTn5, 
represents an interesting case where the contributions of individual components 
are not additive, since changing the method from ATAC-seq to THS-seq while 
keeping the original EzTn5 provides only a subtle improvement, whereas 
replacing EzTn5 with Tn5059 is detrimental to ATAC-seq. Previously 
uncharacterized ATAC-seq bias, where peaks of longer length are preferentially 
captured, and peaks of shorter length are lost, reduces the comprehensiveness 
of ATAC-seq generated chromatin accessibility maps. Furthermore, as an 
unexpected result of this study, an optimized ATAC-seq protocol, is widely 
applicable to many current and future studies on small numbers of cells or single 
cells16. Although the lowest amount of input material used in this study was 100 
cells, THS-seq is compatible with the high throughput combinatorial cell 
barcoding strategy15 and when applied to single cells should lead to substantially 
denser maps of single-cell chromatin accessibility. With THS-seq, we captured 
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>110,000 insertion events per cell. This compares favorably than what was 
recently reported with combinatorial ATAC-seq, with a median of 1,685 reads per 
cell, and scATAC-seq using the C1 device to isolate single cells, with an average 
of 73,000 fragments per cell of those cells that pass filter15, 16. THS-seq is 
compatible with the combinatorial barcoding scheme, which will facilitate a much 
more comprehensive characterization of accessible chromatin landscape in tens 
of thousands of single cells. 
 Chapter 2, in full is an adapted version of the material that appears in 
Genome Biology. Sos BC, Fung HL, Gao DR, Osothprarop TF, Kia A, He MM, 
Zhang K. Characterization of chromatin accessibility with a transposome 
hypersensitive sites sequencing (THS-seq) assay. Genome Biol. 2016 Feb 
4;17:20. Published. The dissertation author was the primary author of all 
material. 
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CHAPTER 3: SINGLE CELL THS-SEQ DEVELOPMENT AND INTEGRATTIVE 
SINGLE CELL ANALYSIS BY TRANSCRIPTIONAL AND EPIGENETIC STATES 
IN HUMAN ADULT BRAIN. 
3.1 Introduction 
Previously it was shown THS-seq is a viable method to assay chromatin 
accessibility in small number of cells. Direct comparisons with ATAC-seq found 
higher sensitivity and more robust capture of open chromatin, resulting in more 
peaks called, smaller peaks being called and more peaks called in distal 
elements. This required designing a new method ensuring each Tn5 insertion 
would results in captured fragments. With the improved sensitivity in THS-seq we 
next wanted to apply the methods to single cells. For this, we adapted THS-seq 
to combinatorial indexing. After proof of concept and optimization of scTHS-seq, 
we then applied the method to biological samples. While methods for 
characterizing chromatin accessibility have been reported16, 17, 26, they remain to 
be demonstrated on highly heterogeneous archived human tissues, like the 
brain, at scale. Here we perform scTHS-seq and snDrop-seq, a new method for 
quantifying nuclear transcripts, on human archived tissue, and then perform an 
integrative analysis of single-nucleus transcriptomes and chromatin maps of 
human tissues.  
3.2 Results 
3.2.1 snDrop-seq design and application to human brain nuclei 
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 To overcome the limitations associated with single-nucleus RNA 
sequencing, we have adapted a droplet-based methodology32 to analyze single 
nuclei, termed snDrop-seq, that we find can provide a higher-scale assessment 
of neuronal and non-neuronal diversity in human post-mortem brain samples.  
The application of this methodology to isolated nuclei necessitated certain 
modifications (see Methods) that included coating all inner surfaces with bovine 
serum albumen (BSA) to prevent non-specific binding by nuclei, and heat 
treatment of droplet-encapsulated nuclei to ensure complete lysis without 
introducing excessive RNA degradation (Fig. 3.1a). Subsequently, we applied 
the snDrop-seq pipeline (Fig. 3.2A) to both the human adult visual cortex 
(Brodmann Area 17 (BA17) or V1) and frontal cortex samples (BA10 and BA6) 
from four different individuals (Table 6). We generated 16,262 visual cortex 
single-nucleus data sets and 9,794 frontal cortex data sets, of which 15,819 and 
8,755, respectively, were resolved into neuronal and non-neuronal cell types 
(Fig. 3.2B-E, Table 7).  These libraries were sequenced to a median of 5,247 
usable reads (2,483 for frontal cortex), with the majority of mapped reads falling 
within intronic regions (Fig. 3.1D-E), and predominantly to the 3’ ends of 
transcripts (Fig. 3.1F), consistent with poly-A capture and 3’-end counting for not 
only mRNA transcripts, but also the pre-mRNA abundant in nuclei48.  In 
comparison with other RNA-seq methodologies (Fig. 3.3), both snDrop-seq and 
scDrop-seq32 methods showed highly comparable, albeit lower, median UMI 
counts and gene detection rates.  However, nuclear data was slightly biased for 
longer genes (Fig. 3.3Q-R), likely reflecting differential transcript processing and 
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export rates associated with genic length and intron fraction48. Overall, we 
detected a median of 1,072 unique transcripts and 826 genes per visual cortex 
nucleus (Fig. 3.3) and 7,422 total genes detected on average per cell type 
(Table 7). Analysis of transcriptional heterogeneity (see Methods) resolved 30 
distinct cellular clusters representing 10 excitatory (Ex) and 14 inhibitory (In) 
neuronal subtypes, and six non-neuronal cells, including: endothelial cells (End), 
smooth muscle cells or pericytes (Per), astrocytes (Ast), oligodendrocytes (Oli) 
and their precursor cells (OPCs) and microglia (Mic) (Fig. 3.2B, Fig. 3.4).  These 
subpopulations showed cell-type or subtype specific expression profiles (Fig. 
3.2C, Table 8), expected marker genes (Fig. 3.2D), and were highly consistent 
with pooled cell populations from the mouse49 and human (temporal lobe)50 
cerebral cortex (Fig. 3.2F).  Comparison with single-cell data generated from the 
mouse visual cortex51 and human temporal lobe52 confirmed broad cell type 
classification and the consistency between nuclear and whole cell data (Fig. 
3.2G).  Neuronal clusters were annotated based on their correlation values with 
subtypes previously identified from SNS in six cortical regions53 (Fig. 3.2H).  In 
addition to the high correspondence, snDrop-seq permitted finer resolution into 
sub-populations (e.g. Ex1 to Ex1a,b of the visual cortex) while showing little 
representation from subtypes not previously observed in these regions (e.g. 
rostral-specific Ex2 found only in frontal cortex and caudal-specific Ex3 found 
only in visual cortex)53.  Otherwise, subtypes resolved were found to be highly 
consistent between these two cortical regions (Fig. 3.2I).  This demonstrates the 
high accuracy of snDrop-seq in resolving neuronal subtype diversity in the 
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Figure 3.1. snDrop-seq metrics.  
A. Violin plot showing the ratio of area size of DAPI staining versus droplet size 
of untreated and heat treated samples, confirming efficient nuclear lysis in 
snDrop-seq.  Left panel: 293T cells pre-stained with DAPI showing cellular, but 
not nuclear lysis inside droplets. Right panel: DAPI staining in droplets after 
applying heat-treatment showing efficient lysis as evidenced by the 
overspreading of DNA stain inside the droplets.  B. Histogram showing 
frequency of total reads (unmapped, multiple mapped and uniquely mapped) 
associated with all quality filtered data sets from the visual cortex.  C. 
Histogram showing frequency of total reads associated with all quality filtered 
data sets from the frontal cortex.  D. Proportion of reads mapped to exons, 5’ 
untranslated regions (UTR) 3’ UTRs, introns, intergenic regions and that are 
unassigned across all quality filtered data sets from the visual cortex.  E. 
Number of reads associated with (D).  F. Gene body coverage for visual cortex 
data sets (library occ5). 
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Figure 3.2. snDrop-seq metrics. Transcriptional profiling with snDrop-
seq resolves major cell types of the visual and frontal cortices.   
A. Overview of single nucleus isolation from the visual cortex (occipital lobe, 
BA17) and frontal cortex (BA6 and BA10) and subsequent snDrop-seq 
procedure.  B. Single nucleus visual cortex data sets (16,262) showed distinct 
clustering, visualized here using t-distributed Stochastic Neighbor Embedding 
(t-SNE).  Unannotated data sets are shown in gray.  C. Heatmap of 
expression of top differentially expressed genes identified across cell types 
and subtypes of the visual cortex (Table 8).  D. Violin plots of expression 
values for type-specific marker genes for the visual cortex.  Number of data 
sets contributing to each cluster is listed.  E. Distinct clustering of the frontal 
cortex data sets using t-SNE. Unannotated data sets are shown in gray. F. 
Correlation heatmaps comparing averaged visual cortex snDrop-seq data 
with average expression values from RNA-seq data from: mouse pooled 
cortical cell types (12) (left, nf = newly formed); human pooled temporal lobe 
cell types (13) (right).  G. Correlation heatmaps comparing average visual 
cortex data with average expression values from single-cell RNA-seq data 
from the mouse visual cortex (14) (left) and human temporal lobe (15) (right).  
H. Correlation heatmap of snDrop-seq-identified neuronal subtypes (visual 
cortex or frontal cortex) compared with subtypes previously identified using 
the C1 single nucleus Smart-seq+ pipeline (SNS, across cortical regions) (7).  
Star indicates distinct region-specific Ex2 and Ex3 sub-populations.  I. 
Correlation of average expression values for cell types and subtypes resolved 
from the visual and frontal cortices.  
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Figure 3.3. Comparison of single-cell/nucleus RNA-seq methodologies. 
A. snDrop-seq clusters from the human adult visual cortex visualized by t-
SNE (from Fig. 1B).  B. Mouse retina data generated from single cells (sc) 
using the Drop-seq method and previously annotated54 were visualized using 
a maximum of 100 cells per cluster by t-SNE. C. Mouse embryonic brain 
(E18) data sets generated on the 10X Genomics platform were clustered and 
visualized by t-SNE. D. Embryonic human midbrain data sets generated on 
the Fluidigm C1 platform and previously annotated55 were visualized by t-
SNE. E-H. Histograms of detected molecules (number of UMI) for associated 
quality filtered data sets. I-L. Histograms of detected genes for associated 
quality filtered data sets.  M-P. Coverage (number of UMI per gene detected) 
for associated quality filtered data sets.  Q. Scatter plot showing average 
expression values for protein-coding genes across all quality filtered snDrop-
seq samples (log transformed) and their associated genic length.  R.  Scatter 
plot showing average expression values for protein-coding genes across all 
quality filtered scDrop-seq samples (log transformed) and their associated 
genic length. 
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Figure 3.4. snDrop-seq resolves neuronal and non-neuronal 
subpopulations.   
A. Cluster dendrogram showing unsupervised grouping of visual cortex non-
neuronal, excitatory and inhibitory neuronal cell types or subtypes.  B. t-SNE 
plot as shown in Fig. 1B.  C. t-SNE plot as in (B) showing UMI read depth.  
Non-neuronal cell types show lower coverage than neuronal subtypes. D. t-
SNE plot as in (B) showing batch identity (see Table 6) and the absence of any 
significant batch-dependent drivers for nuclear data clustering. E. t-SNE plot as 
in (B) showing individual patient identity (see Table 6).   F-J. Same as for B-E 
except showing frontal cortex data.  K. t-SNE plot as in (G) showing BA region 
(see Table 6). L. Total number of UMI counts for each cell type or subtype from 
the visual cortex. M. Total number of genes detected for each cell type or 
subtype from the visual cortex. N-O. Same as for L-M except instead showing 
data from the frontal cortex. 
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cerebral cortex though profiling a larger cell cohort compared with our previous 
SNS efforts, albeit with ~1500-fold lower per cell sequencing depth. 
 Excitatory neurons of the visual cortex marked by expression of SLC17A7 
(Fig. 3.2D) were resolved into 10 distinct subtypes, showing enriched marker 
gene profiles (Fig. 3.5A, Table 9) and that could be distinguished by their spatial 
orientation within the cortex56 (Fig. 3.6A, B).  In addition, we identified specific 
subpopulations located within cortical layers, including the CARTPT+RASGRF2+ 
Ex1b of upper layer 2; the distinct HS3ST5+PCP4- (Ex5b) and 
HTR2C+PCP4+TLE4+ (Ex6a) subpopulations in layer 5, the latter bordering on a 
HTR2C-TLE4+ (Ex6b) layer 6 population; and the NR4A2+SYNPR+ Ex8 
subpopulation in layer 6b (Fig. 3.6B). Inhibitory neurons of the VC, marked by 
shared expression of GAD1 (Fig. 3.2D), were resolved into 14 subtypes showing 
enriched marker gene expression (Fig. 3.5B, Table 10), distinct profiles of 
canonical interneuron markers (e.g. VIP, RELN, PVALB, SST) as well as sub-
type restricted expression (e.g. SHISA8, CA3, CA8) (Fig. 3.6C).  We were further 
able to resolve spatially distinct inhibitory neuron subpopulations, including: layer 
1 RELN+CCK+CNR1+ In1a; upper layer VIP+CALB2+TAC3+ In1d; PVALB+CA8+ 
In6a concentrated around layer 4, as well as the more peripheral PVALB+TAC1+ 
In6b; and two distinct SST positive subtypes, including the upper layer 
SST+CALB1+ (In7) and lower layer SST+CALB1- (In8) subpopulations (Fig. 
3.6D).  Furthermore, given the strand-specificity of snDrop-Seq, we characterized 
the expression patterns of natural antisense transcripts (NATs), which was not 
possible with SNS53. We identified 26 NATs to be differentially expressed across 
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cell clusters (Table 12, Fig. 3.7), including inhibitory neuron-specific expression 
of DLX6-AS1 potentially involved in interneuron specification during 
development57, 58 (Fig. 3.7B). Furthermore, we detect a higher proportion of 
neuronal data sets in the visual over frontal cortex consistent with a higher 
neuronal density in this region (Fig. 3.6E)59.  Cell type proportions detected by 
snDrop-seq were somewhat consistent with those from single-cell analyses on 
the temporal cortex, with the exception of astrocytes and endothelial cells which 
appear under-represented.  This may reflect a bias in sample processing or a 
potential limited detection based on lower transcript levels for these cell types 
(Fig. 3.4L-O).  Therefore, snDrop-seq provides not only a more comprehensive 
cellular profile of human postmortem tissues (Fig. 3.6E), but also insights into 
region-specific cell-type proportion differences and strand-specific transcriptomic 
dynamics, attributes not achievable using previous methodologies53.     
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Figure 3.5. Subtype-specific gene enrichments and tissue-specific 
proportions.  
A. Heatmap of top 10 differentially expressed protein-coding marker genes 
enriched across excitatory neuron subtypes (Table 9).  B.  Heatmap of the top 
10 differentially expressed protein-coding marker genes enriched across 
inhibitory neuron subtypes (Table 10). C. Cell type sampling rates from 
single-cell RNA-seq on the temporal lobe52 compared with snDrop-seq 
sampling rates from the visual and frontal cortices. 
  
63 
 
 
Figure 3.6. snDrop-seq identifies molecularly and spatially distinct 
neuronal subtypes. 
A. Violin plots showing gene expression values of layer specific (7, 16) and 
subtype-enriched markers for excitatory neuronal subtypes.  B. RNA in situ 
hybridization (ISH) stains (Table 11) of the visual cortex for select marker 
genes shown in (A). C. Violin plots showing expression values for classical 
interneuron marker genes (7) and subtype-enriched transcripts.  D. RNA ISH 
stains (Table 11) of the visual cortex showing select stains for markers in (C) 
and predicted spatial distribution of associated inhibitory neuron subtypes. E. 
Proportion of cell types and subtypes detected from snDrop-seq interrogation 
of the human visual cortex compared with the frontal cortex. 
  
64 
 
 
 
Figure 3.7. Cell-type-specific expression of NAT markers and stage-
specific expression of NAT and protein-coding markers.  
A. Violin plots of expression values for excitatory neuronal, pan-neuronal, 
inhibitory neuronal, astrocyte and oligodendrocyte NAT marker genes. B. The 
expression of 7 differentially expressed NAT marker genes in brains from 
different ages. Each curve represents one differential expression region of NAT 
gene. All values are normalized to the highest expression level of each region 
among all development stages. F, fetal; I, Infant; C, child; T, teen; A, adult; S, 
senior or age ≥ 50. 
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3.2.2 scTHS-seq design and application to human brain nuclei 
 The epigenetic state of a cell can provide valuable information about its 
overall phenotypic potential, and reveal gene regulatory processes responsible 
for establishing and maintaining its function. To investigate the epigenetic 
configuration of different cells in the human adult cortex at scale, we developed a 
single-cell DNA accessibility assay by integrating THS-Seq60, which uses in vitro 
transcription and an engineered super-mutant of Tn5 transposase61 to achieve 
higher sensitivity and better coverage of distal enhancers than ATAC-seq5, with 
combinatorial cellular indexing26 based on a set of 384 customized barcoded 
transposomes (Fig. 3.8A, Fig. 3.9). scTHS-seq, confirmed to have a low doublet 
rate and generating high quality data (Fig. 3.10, Fig. 3.11, Table 13), identified 
287,381 peaks associated with DNA accessibility regions in combined data sets, 
covering 144 million base pairs with unique genomic alignments, at the clonal 
rate of ~60% and doublet rate of 11.7%. In total, we generated 14,870 quality-
filtered single-nucleus data sets having a median of 11,889 unique reads per cell 
that, from comparison with merged datasets, were confirmed to detect accessible 
regions (Fig. 3.12, Fig 3.13).  To identify epigenetically-distinct subpopulations 
within this scTHS-seq dataset, we first used an unbiased approach. We modeled 
the probability of observing reads from a genomic site in a given cell as a 
censored Poisson process (see Methods), which accounts for the fact that the 
scTHS-seq signal from even the most accessible site will saturate after only a 
few reads. This approach revealed multiple distinct subpopulations in both the 
visual and frontal cortex (Fig. 3.8B-D, Fig. 3.14), with proportions that are more 
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favorable to non-neuronal cell types than snDrop-seq (Fig. 3.6E), suggesting that 
snDrop-Seq is less efficient in sampling non-neuronal cells, either due to data 
quality filtering that is biased against cells transcribing fewer transcripts or lower 
efficiency in packaging smaller nuclei into droplets. Characterizing the identity of 
epigenetically-defined subpopulations, however, is more challenging than in the 
case of transcriptionally-defined subsets, as functional roles of most regulatory 
sequences remains poorly annotated. Based on the functional annotation of the 
genes neighboring differentially-accessible sites, we could distinguish five glial 
cell populations and three neuronal cell populations having 97,672 differential 
accessibility peaks (Table 13) that when aggregated into accessibility profiles 
could be used to identify putative regulatory regions within a given locus (Fig. 
3.8D). 
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Figure 3.8. Chromatin accessibility profiling resolves major cell types of 
the visual cortex.  
A. Implementation of scTHS-seq with a Tn5 supermutant and cellular 
combinatorial indexing. First, 384 uniquely barcoded transposomes are added 
to 500,000 to 1 million mixed mouse and human nuclei that have been 
aliquoted into a 384 well plate, with one uniquely barcoded transposon added 
per well. Species nuclei are mixed to reduce and calculate collision rates, and 
for quality control. Next, high efficiency tagmentation is performed, followed 
by EDTA inactivation, pooling, and FACS redistribution of 100 nuclei/well into 
96 well plates. scTHS-seq RNA-seq is performed with each well treated as 
one reaction, followed by PCR indexing, pooling and high throughput 
sequencing of libraries. Optimally ~25,000 total single cell datasets are 
recovered per run, the sum of mouse and human nuclei recovered. B. tSNE 
plot of major subpopulations of visual cortex nuclei, clustered based on the 
overall similarity of the chromatin accessibility profiles. C. Pie chart depicting 
major visual cortex subpopulations identified in B. D. Identification of cell 
specific DNA accessibility peaks over the promoter and regulatory region of 
Alzheimer’s disease associated gene PICALM. Glial specific peaks are over-
represented. The top tract is all cells merged to generate peaks. Each cell 
subpopulation tract is represented by 100 randomly selected single cells of 
cells that had reads in the depicted region, where each row represents a 
single cell and each dot is a read. The color of highlighted peak regions 
corresponds to the cell type specificity of the peak, with each subpopulation 
tract title a specific color. Boxed regions highlight specific cell type specific 
peaks. The gray box highlights a glial cell specific peak. Nonspecific peaks 
are not highlighted. 
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Figure 3.9. Customized scTHS-seq transposon design and sequencing 
library fragments generated.  
A. The design of the transposon, which contains a mosaic end for Tn5 
binding, read primer sequence for sequencing, the r5 barcode which is unique 
to every transposon, an i5 connector sequence used in PCR amplification and 
a T7 promoter for in vitro transcription amplification. To generate barcoded 
transposome complexes, first transposon is annealed to the RC mosaic end, 
then transposase is added. B. Depiction of sequencing ready fragments 
generated after library generation. Fragments contain i5/i7 adaptors and 
barcodes, the r5 transposon barcode, Read1 sequencing primer, and 
captured genomic DNA. The i5 and r5 barcodes are read in one sequencing 
read, with sequencing progressing through the linker region and ending with 
reading the r5 barcode. 
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Figure 3.10. Confirmation of in vitro transcription and barcoded library 
generation in scTHS-seq.  
A. Whole reactions were purified with SPRI binding buffer, since beads were 
already in solution. Then whole reactions were run on a 6% TBU gel and 
visualized with a UV-transilluminator. Plate 5 and plate 6 quality control (QC) 
samples consisted two 100 cell samples, and two NTC samples. Cells were 
FACS sorted, and NTCs consisted of only PBS with no FACS sorting. B. 
Each 96 well plate had 12-6% TBE gels run for validation of library generation 
with visualization on a UV-transilluminator. Shown is one example of 12 wells 
from a 96 well plate, where we can see library amplification in the expected 
size range that is size selected after pooling all samples. 
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Figure 3.11. Sequencing statistics and collisions calculations for scTHS-
seq.  
A. Frequency of the log10 number of unique reads in each possible barcode 
combination in the hg38 noAlt dataset. B. Frequency of the log10 number of 
unique reads in each possible barcode combination in the mm10 noAlt 
dataset. C. Frequency of the number of percentage clonal reads in each 
possible barcode combination in the hg38 noAltdataset. Clonal read statistics 
were rounded to the nearest whole percent before calculating. D. Frequency 
of the number of percentage clonal reads in each possible barcode 
combination in the mm10 noAlt dataset. Clonal read statistics were rounded 
to the nearest whole percent before calculating. E. Collisions plot examining 
the ratio of unique reads mapped to human and unique reads mapped to 
mouse in each unique barcode combination. Plot of human nuclei in blue, 
mouse nuclei in green, human mouse collision nuclei in red, and <500 reads 
excluded data. See Methods for determination of which data sets are 
considered collisions. F. Density plot of the ratio of unique reads mapped to 
human and unique reads mapped to mouse in each unique barcode 
combination. Human nuclei are in blue, mouse nuclei are in a green dotted 
line, and collisions in a red dotted line. <500 reads excluded data was 
excluded in this analysis. G. Theoretical and experimentally derived collision 
rate percentages. Graphed are the detectable human/mouse collision rate, 
expected human/human collision rate, and expected mouse/mouse collision 
rate. The expected collision rates cannot be directly measured since they are 
the same genome and would appear as only mouse nuclei or only human 
nuclei on a collisions plot. 
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Figure 3.12. scTHS-seq Unique read statistics.  
A. Violin plot of unique read counts for nuclei that pass filter and nuclei that 
pass filter with multi-mappers removed. The blue dot in the middle of the 
violin plot is the average number of unique reads and the red dot in the 
middle of the violin plot is the median number of unique reads. B. Zoom in 
graphic from 0 to 80,000 unique read counts for nuclei that pass filter. 
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Figure 3.13. Visualization of merged single cell data and individual single 
cell datasets.  
All unique reads in single cell datasets that passed filter when multi-mappers 
were removed were merged to generate the merged tract. Single cell datasets 
that had reads present in the chromosome 17 from 8,100,000 to 8,250,000 
base pairs locus were randomly sampled and plotted in the single cell tracts 
section. Each black dot represents a unique read. UCSC genes are overlaid in 
the on the bottom tract. 
 
Figure 3.14. Epigenetic heterogeneity in the frontal cortex, as measured by 
scTHS-seq.  
A. The tSNE embedding showing the classified sub populations. B. Pie chart 
visualizing the distribution of cell types.   
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3.2.3 scTHS-seq and snDrop-seq data integration 
 To establish more precise correspondence between transcriptional and 
epigenetic states of different subpopulations, we sought to identify cells 
corresponding to transcriptional subpopulations in the scTHS-seq data as well as 
cells corresponding to epigenetic subpopulations in the snDrop-seq data. We 
trained a gradient boosting model (GBM) to predict differentially accessible 
genomic sites based on the differential expression patterns (Fig. 3.15A, Fig. 
3.16) and a separate GBM to predict differential expression based on differential 
accessibility (Fig. 3.16, Fig. 3.17) using features such as the distance of a site to 
a gene, degree of differential expression or accessibility of the site or gene, 
among others (see Methods). While the ability to predict differential expression 
or differential accessibility of any individual gene or site is limited (Fig. 3.16B, E), 
joint consideration of multiple genes or sites allows for confident cell type 
classifications (Fig. 3.15B, C, Fig. 3.16C, F, Fig. 3.17B, C). Applying such 
models to classify scTHS-seq cells based on the differentially expressed genes 
between major cell types, we were able to resolve astrocytes, oligodendrocytes, 
inhibitory and excitatory neurons with high sensitivity and precision in both the 
visual cortex (Fig. 3.15B) and frontal cortex (Fig. 3.17D). Similarly, applying such 
models to classify snDrop-seq cells based on the differentially accessible sites 
between major cell types, we were likewise able to resolve these cell types with 
high sensitivity and precision in both the visual cortex (Fig. 3.17B, C) and frontal 
cortex (Fig. 3.17E). Although layer 4 excitatory neurons (L4 = Ex2-4) were not 
distinguishable from layer 5 and 6 excitatory neurons (L5/6 = Ex5-8) from an 
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unbiased analysis of scTHS-seq data alone (ExB in Fig 3.8B), integrating 
differential expression information from the higher resolution snDrop-seq data 
allowed us to identify relevant differentially accessible sites to further partition 
scTHS-seq clusters (Fig. 3.15D). Similarly, such integrated analysis allowed us 
to identify epigenetic differences relevant to inhibitory neuron subtypes that 
appear distinguished by their developmental origin from subcortical regions of the 
medial or lateral/caudal ganglionic eminences53, 62, 63 (Fig. 3.15E). Thus, despite 
lower intrinsic cell type resolution of accessibility data compared to transcription, 
computational integration of both scTHS-seq and snDrop-seq allowed us to 
reconstruct detailed epigenetic profiles of fine-grained cell types within the brain, 
enabling investigations of the regulatory processes active within each cell type. 
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Figure 3.15. Differential gene expression predicts differential chromatin 
accessibility to map corresponding transcriptional and epigenetic 
subtypes.  
A. Average expression genes significantly upregulated (Z > 1.96) in each major 
cell type in the visual cortex are shown, with red corresponding to high 
expression of blue for low expression. A GBM model predicts differential 
accessibility of sites observed in scTHS-seq based on the predicted 
association of sites with the differentially expressed genes (see Methods). 
Predicted differentially accessible sites are visualized with red corresponding to 
high accessibility and blue for low accessibility. B. Predicted cell type identities 
are assigned based on the cell type with the maximal joint score on predicted 
differentially accessible sites. C. Prediction performance is measured by ROC 
curves and AUC comparing joint scores and previously inferred cell type 
identities identified from scTHS-seq analysis alone. D. Differential expression 
among excitatory neuronal subtypes predicts differentially accessible regions 
to further divide excitatory neuronal subtypes in the scTHS-seq data. E. 
Differential expression among inhibitory neuronal subtypes predicts 
differentially accessible regions to further divide inhibitory neuronal subtypes in 
the scTHS-seq data. 
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Figure 3.16. Probabilistic inference of differential expression and 
differential accessibility signals.  
A. Predicting differential accessibility of sites from differential expression. 
Astrocytes (Ast) and Oligodendrocytes (Oli) identified independently from 
snDrop-seq and scTHS-seq data analysis are used for training and testing. 
Significantly differentially upregulated genes (Z > 1.96) in Ast and Oli are 
visualized (top) with red indicating higher aggregate expression of genes. 
Predicted differential accessibility is visualized (bottom) with red indicating 
higher aggregate predicted accessibility and blue indicated lower aggregate 
predicted accessibility. True cell population assignments are labeled. Genes 
highly upregulated in Ast snDrop-seq population predict sites highly 
accessibility in the Ast scTHS-seq population and similarly for Oli. B. A receiver 
operating characteristic (ROC) curve is used to illustrate the accuracy of 
predicting the differentially accessible sites within the proximity of the 
differentially-expressed genes. C. The ROC curve shows the performance of 
cell classification based on a multi-site predicted differential accessibility 
signature. In this case, we assess the ability of the average expected 
differential accessibility inferred from the differential expression signature to be 
able to distinguish Ast and Oli groups in the scTHS-seq data. D. Predicting 
differential expression from differential accessibility profiles. E. ROC of 
predicting differential of an individual gene is shown. F. ROC curve and 
visualization of the combined differential expression scores inferred from the 
differential accessibility signature comparing Ast and Oli groups. 
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Figure 3.17. Cell type prediction based on probabilistic inference of 
differential expression and differential accessibility signals.  
A. Significantly differentially accessible sites (Z > 1.96) for each major cell type 
from scTHS-seq for the visual cortex identified and visualized with red 
corresponding to high accessibility of blue for low accessibility. A GBM model 
predicts differential expression of genes observed in snDrop-seq based on 
select features (see Methods). Predicted differentially expressed genes are 
visualized with red corresponding to high expression and blue for low 
expression. B. Predicted cell type identities are assigned based on the cell type 
with the maximal joint score on predicted differentially expressed genes. C. 
Prediction performance is measured by ROC curves and AUC comparing joint 
scores and previously inferred cell type identities identified from snDrop-seq 
analysis alone. D. Cell type prediction based on probabilistic inference of 
differential accessibility from differential expression for the frontal cortex. E. 
Cell type prediction based on probabilistic inference of differential expression 
from differential accessibility for the frontal cortex.   
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3.2.4 Integrative transcription factor analysis 
 Having established the cell-type identity of each epigenetically-distinct 
subpopulation, we sought to identify the transcription factors (TFs) relevant to the 
regulatory state of each cell type. To do so, we looked for TFs whose predicted 
binding sites are over-represented within regions of differential chromatin 
accessibility distinguishing a given cell type. Screening a set of 379 TFs (Table 
14) with position weight matrices from the JASPAR database64, we identified 195 
TFs factors showing statistically significant (FDR <10-5) association with at least 
one of the cell types (Fig. 3.18A-B, Table 15). As expected, TFs associated with 
the neuronal subpopulations (ExA, ExB, and In) are distinct from TFs with 
binding relevant to non-neuronal subpopulations (Oli, Ast, OPCs, Mic, and End) 
(Fig. 3.18B). We also recover TFs with known relevance of cell subtypes. For 
instance OLIG1, an oligodendrocyte progenitor marker65, 66,  showed enriched 
binding within the Oli cluster. As an independent validation, we integrated 
snDrop-seq data to confirm that the TFs showing significant association with a 
particular cell type also tend to show higher expression levels within that cell type 
(Fig. 3.19). Some of TFs achieve positive feedback by targeting their 
endogenous loci. For instance, PKNOX2 has 8 of such binding sites within its 
own locus, 5 of which are differentially accessible, mostly in neuronal 
subpopulations compared to glia (Fig. 3.18C), highlighting the potential of this 
approach to identify positive self-regulation. 
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Figure 3.18. Mapping of transcription factor binding status and disease 
risk variants to specific brain cell types. 
A. Schematic of TF analysis. Briefly, putative TF binding sites (TFBS) were 
identified within all hypersensitive sites based on PWMs matching. To identify 
relevant factors for a given cell type, sites showing differential accessibility 
within that cell type were tested for statistical enrichment of different TFBS. B. 
Heatmap of TF association to epigenetic subpopulations. Each column is a TF. 
Each row is an epigenetic subpopulation. Select TFs are annotated. C. 
PKNOX2 transcription factor shows potential for self-regulation. The IGV view 
of a representative region for tracks corresponding to 5 subpopulations 
highlights patterns of differential accessibility in the PKNOX2 gene. 
Differentially-accessible sites within PKNOX2 are noted with blue boxes. 
Putative binding sites for PKNOX2 based on PWM sequence similarity within 
PKNOX2 are noted with red boxes. 
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Figure 3.19. Gene set enrichment analysis plots to assess significance of 
identified TFs with expression of TFs. 
A. Oligodendrocyte associated TFs are significantly upregulated based on 
ranked fold-change comparing TF expression in oligodendrocytes to neurons 
and astrocytes. B. Oligodendrocyte associated TFs are significantly depleted in 
upregulated TFs based on fold-change comparing neurons to oligodendrocytes 
and astrocytes.   
 
  
81 
 
 
3.2.5 Mapping disease risk variants to susceptible cell types 
 Cell-type specific epigenomics information has been highly valuable for 
identifying pathogenic cell types and specific regulatory mechanisms underlying 
many common genetic diseases67-69, yet brain diseases remained inadequately 
understood due to the lack of epigenomic maps with any cell-type resolution.  To 
fill this gap, we obtained NIH GRASP database SNPs that were identified from 
genome-wide association studies (GWAS) as significant (p-values < 10-6) in ten 
brain related disorders, as well as seven additional diseases unrelated to the 
brain for controls.  Given that causal variants are often located at different 
positions in linkage disequilibrium with the GWAS SNPs, we searched for 
enrichment of DNA accessibility regions in 100kb windows centered on all GWAS 
SNPs of a given disease, and assessed the significance by random permutations 
(Fig 3.20A, see Methods). This analysis identified strong enrichments in multiple 
cell types or sub-types, contrasting with an alternative possibility of uniformity 
(Fig. 3.20B-C, Fig. 3.21, Table 18), including: highly significant enrichment for 
common risk variants linked to Alzheimer’s Disease in Mic and Oli cells, 
Schizophrenia in ExB and In neurons, Mic and Oli cells; ALS in In and Ast cells; 
Parkinson’s Disease for the ExB and In neurons; Bipolar disorder for all Ex 
neurons and Mic; Autism for all Ex and In neurons; ADHD for al Ex and In 
neurons, Oli and Opc; ALS in In and Ast cells; with significant associations for 
Epilepsy for all Ex and In neurons and Oli, and for Depression for all Ex neurons 
and Mic. Significant enrichment for Oli was found in glaucoma, and similarly in 
the other non-brain diseases significant enrichments were not found in any 
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neurons. However, enrichments were found in the most closely related cell types 
to those implicated in the disease. For the autoimmune diseases Crohns, Celiac 
and Type I diabetes, Mic and End were enriched, while in lung disease Mic was 
enriched. No enrichment was found for the two non-brain related diseases 
(Chronic kidney disease and prostate cancer), demonstrating the specificity of 
these analyses. While further validation is required, our chromatin maps provide 
a new framework through which new aspects of brain diseases can be 
understood at the level of specific cell types or subtypes. 
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Figure 3.20. Mapping of common disease risk variants to specific brain 
cell types. 
A. Method used to map disease risk variants to specific cell types. Briefly, 
GWAS SNPs were obtained for each disease, extended to 100KB, merged, the 
top 50 most significant SNPs selected, number of peaks in overlaps counted, 
peaks permuted and the number of peaks counted in each region for each 
permutation, then lastly Z-scores were calculated. B. Heat map representing 
the enrichment Z-scores across 8 cell clusters (rows) for 10 brain diseases 
(columns) and 7 unrelated diseases. Dark purple and purple represent a 
significant Z-score over 1.96, where light purple, gray and light green represent 
an insignificant Z-score, and green represents a significant negative 
association with a Z-score less than -1.96. C. Z-scores for the enrichment of 
GWAS SNPs in the open chromatin of ExB, In, ExA, Oli, Opc, Ast, End, Mic, 
populations were overlaid onto the cell clusters. Six brain disorders are shown. 
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Figure 3.21. Mapping of disease risk variants to specific brain cell types 
in brain diseases and non-brain diseases. 
Disease risk variants were mapped to specific brain cell types in four brain 
diseases and seven non-brain diseases, including three autoimmune diseases 
(Crohn’s disease, Celiac disease, Type I diabetes). Dark purple and purple 
represent a significant Z-score over 1.96, where light purple, gray and light 
green represent an insignificant Z-score, and green represents a significant 
negative association with a Z-score less than -1.96. C. Z-scores for the 
enrichment of GWAS SNPs in the open chromatin of ExA, In, ExB, Oli, Opc, 
Ast, End, Mic, populations were overlaid onto the cell clusters. 
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3.3 Discussion 
 Reconstruction of cellular composition is an important aim towards 
understanding the human brain. Our study provides a first demonstration of an 
integrative single-cell analysis on the human adult brain, utilizing two highly 
scalable methods for acquiring transcriptional and epigenetic information from 
post-mortem tissues: snDrop-Seq and scTHS-seq. Using nuclei isolation to 
overcome challenges associated with processing of post-mortem tissues, we 
recovered all known non-neuronal and most neuronal subtypes in human adult 
cortex. These assays rely on a much shallower sampling of many more cells than 
our previous efforts, yet we were able to resolve these cell subpopulations and 
provide informative aggregate profiles for each subtype. Our results underscore 
the power of sparse sampling of single cells in complexed tissues at a massive 
scale: as long as the data from the single cells are informative enough for 
clustering and “virtual sorting” into different groups25, 70, they can be combined 
into aggregate profiles that are as rich as bulk sequencing of different cell 
populations. 
We demonstrate a computational strategy for mapping between 
transcriptional and corresponding epigenetic states that can be used to 
reconstruct aggregate epigenetic profiles for fine-grained cell types. Such profiles 
provide valuable insights into the regulatory processes and elements shaping the 
identity of different cell types, as well as their relevance to human disease. While 
previous studies have identified pathogenic cell types for many human common 
diseases, our analysis enabled an assessment of the relative impacts by 
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common genetic risk alleles to multiple cell types in an organ. It provides a 
coherent framework to consolidate previous findings, such as the relative 
contributions of glia, microglia and neurons to sporadic Alzheimer’s disease71. 
Such information is critical for identifying effective therapeutic targets. Generating 
multiple types of –omics maps from single cells en mass also enabled us to 
leverage the strength of each method to improve the confidence of cell type 
assignment, greatly enriching cell annotations. This combined approach thus 
represents a highly scalable strategy for systematic construction of atlases 
composed of single-cell data for human organs like the brain and eventually, for 
the full human body. 
Chapters 3, in full is an adapted version of the material that has been 
submitted for publication. Blue B. Lake†, Song Chen†, Brandon C. Sos†, Jean 
Fan†, Yun Yung, Gwendolyn E. Kaeser, Thu E. Duong, Derek Gao, Jerold 
Chun*, Peter Kharchenko*, Kun Zhang*. 2017. Integrative single-cell analysis by 
transcriptional and epigenetic states in human adult brain. In revision. The 
dissertation author was the co-primary author of all material. 
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CHAPTER 4: Conclusions 
Currently there are two single cell methods to assess chromatin 
accessibility in single cells, scATAC-seq and scDNase-seq17, 26. In this 
dissertation we improve upon these methods by developing a high throughput 
and high sensitivity assay, scTHS-seq, to assess chromatin accessibility in single 
cells and address the shortfalls of current methods. Initially we demonstrate THS-
seq is the highest sensitivity chromatin accessibility assay on bulk samples and 
is able to generate high quality data. We assessed chromatin accessibility in 100 
cells, and generated data comparable to data generated in 50,000 cells by 
ATAC-seq and millions of cells by DNase-seq. The significant finding was that 
with THS-seq we were able to find more distal elements, peaks, and smaller 
peaks, thus providing more information about regulatory regions than current 
methods. We believe this is due to method design, resulting in the preferential 
capture of open chromatin compared with ATAC-seq. When applied to biological 
samples this can help provide direction on which regions are important for 
regulation and should warrant further investigation as well as elucidate functions 
of previously unannotated regulatory regions. Additionally, we characterized bias 
in ATAC-seq due to method design that was not found in THS-seq, and should 
be taken into account during data analysis. 
 Single cell DNA accessibility assays have been developed are able to 
provide either high sensitivity or high throughput data, but not both. Single cell 
DNase-seq is not high throughput, with one reaction per well per cell17. 
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Meanwhile, scATAC-seq utilizing combinatorial indexing can generate thousands 
of cells worth of data in a single experiment, however sensitivity is low26, which 
has also been found by a collaborator (unpublished data). Recently Buenrostro et 
al. has shown scATAC was able to assay ~2,200 cells utilizing the C1 autoprep 
system, however this is ~5X-7X less cells than what a single scTHS-seq 
experiment has been able to generate. With higher throughput and higher 
sensitivity of scTHS-seq, now large single cell datasets can be generated quickly, 
and with high data quality, opening new avenues of data analysis that were not 
possible before. Additionally, with higher throughput we can still cluster cell types 
based on sparse sampling. These large datasets can then be leveraged for 
generating new biological insights, and integration with other single cell omics 
datasets to provide a global picture of regulatory states in cells. 
 Several studies have shown integration of bulk DNA accessibility data with 
other omics datasets and application to find novel biological insights29, 30. In this 
dissertation we demonstrate integration of data from scTHS-seq and snDrop-seq 
on human brain nuclei to help refine clustering. With single cell analyses, 
samples no longer need to be sorted by FACS or other methods into respective 
cell types, as each single nucleus or cell is assayed individually. However, with 
the case of the brain nuclei, separation by sorting could not be performed since 
FACS markers delineating cellular identity are usually on the cellular membrane. 
Samples can now be grouped computationally using gene markers in accessible 
regions. Epigenetically similar cellular populations can be further partitioned by 
integrating RNA expression data, providing a higher resolution epigenetic picture 
89 
 
 
of the cell types present within the dataset. Our findings demonstrate DNA 
accessibility may be defining broad cell type classes, while snDrop-seq and RNA 
expression profiles may define specific cell types within those classes. 
Development of omics data integration methods provide a framework for 
clustering and identifying cells to provide a biological structure to samples 
containing diverse cell types. 
In previous GWAS studies on human brain diseases, variants have been 
linked to disease. However, further studies are needed to implicate specific cell 
types and brain regions in disease and shed light on the causative mechanisms. 
Human brain samples are also difficult to obtain so many brain studies are 
performed on mouse or other model organisms, which though informative may 
not have direct functional correlation to human brains. Here we demonstrate 
mapping of disease risk association to specific cell types in brain diseases using 
chromatin accessibility data, which to our knowledge has not been performed 
before. For each disease, this provides a global view of the most susceptible cell 
types. We also examined the specificity of transcription factor motifs to cell types, 
thus helping us further define the cell subpopulations classified. This analysis 
framework can be applied to any other human organ scTHS-seq data is 
generated from and elucidate the most probable cell types involved in disease 
susceptibility.  
 In summary, we have demonstrated development of a highly sensitivity 
chromatin accessibility assay on minute cellular inputs, and on single cells. To 
demonstrate biological application, we performed scTHS-seq on human brain 
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samples, performed an integrative data analysis with snDrop-seq transcriptomic 
data, defined cell type specific transcription factor landscapes, and associated 
human brain cell types with susceptibility to brain diseases. 
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APPENDIX A: THS-SEQ MATERIALS AND METHODS 
Cell culture 
GM12878 lymphoblastoid cells were obtained from Coriell Cell Repositories and 
maintained in RPMI 1640 with 1% Penstrip and 10% FBS. Cells were kept in 
suspension at 37°C and were harvested when suspensions reached optimal 
density. Cell numbers were quantitated with a hemocytometer (Biorad), pelleted 
at 250 x g for 4 minutes and washed twice with a volume of PBS sufficient to 
obtain ~1,000,000 cells per milliliter in ~1 mL of PBS, and diluted as needed in 
PBS for experiments. All biological replicates were performed with material from 
the same cell culture flask, with independent running of the assays. When cells 
were diluted to 100,000 cells per milliliter they were quantitated again on the 
hemocytometer. 
 
Transposome generation 
The transposon consisted of two DNA fragments synthesized by IDT, T7tspn-
top2 (PAGE purified) and T7tspn-bot (Supplementary Table 5). These two 
fragments were incubated together to form annealed transposon at a 
concentration of 30 μM per oligo in Qiagen EB buffer for 2 minute at 95°C, and 
cooled to room temperature at 0.1°C/s. Transposome generation by addition of 
transposase and annealed transposon, using either EzTn5 or Tn5059 was 
performed at Illumina. Prepared transposome was stored at -20°C. 
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Cell lysis, tagmentation and DNA fragment processing 
Cells were concentrated and aliquoted so the total number of cells was present in 
1 μL optimally. Cells were lysed in 1X lysis buffer in reaction (10X concentration: 
100 mM Tris-HCl pH 7.5, 100 mM NaCl, 30 mM MgCl2, 1% NP40), at room 
temperature for 3 to 5 minutes by adding 1.0 μL of 2X lysis buffer to the cell 
mixture. Next, the transposition reaction was carried out at 37°C for 30 minutes 
by adding 1.0 μL tagmentation buffer (5X concentration: 165 mM Tris-OAc pH 
7.8, 330 mM K-OAc, 50 mM Mg-OAc, 80% dimethylformamide), 1.0 μL nuclease 
free water, and 1.0 μL of prepared transposomes (added last) to lysed cells for a 
total reaction volume of 5 μL. EzTn5 transposomes were added at a final 
concentration in reaction of 0.5 μM, and Tn5059 transposomes at a final 
concentration in reaction of 0.7 μM. After transposition, reactions were brought to 
15 μL with nuclease free water, and 15 μL of 8M Guanidine HCl was added to 
degrade chromatin associated proteins and transposase. Next, reactions were 
purified with 1.8X (54 μL) SPRI beads. After the final wash with 80% ethanol and 
brief air drying of SPRI beads, 9.6 μL of nuclease free water was added. 
Importantly, the purified DNA products were not eluted off beads, and DNA 
products, nuclease free water, and beads remained together in solution. Gap fill-
in was performed by addition of 2.4 μL of 5X Taq polymerase solution (NEB), 
mixed thoroughly, and incubated at 72°C for 3 minutes. 
 
In vitro Transcription 
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DNA was used directly, in the same tube, and remaining in solution with SPRI 
beads after gap filling for in vitro transcription. Standard protocol with the 
MAXIscript® T7 Kit (Ambion) was followed. The 10X transcription buffer was kept 
at room temperature, and if crystals were present, heated slightly at 37°C until 
crystals dissolved and returned to room temperature. Also as per manufacturer’s 
recommendation, after briefly thawing, ribonucleotides were stored on ice. 
Reactions were assembled at room temperature, with addition of 2 μL 10X 
transcription buffer, 1 μL 10 mM ATP, 1 μL 10 mM CTP, 1 μL mM GTP, 1 μL 10 
mM UTP and 2 μL T7 enzyme mix to 12 μL of reaction products. Reactions were 
incubated at 37°C for 16-19 hours. After in vitro transcription, RNA was purified 
with Zymo RNA Clean and Concentrator and eluted with 10 μL nuclease free 
water. For purification, reactions were brought to 40 μL with nuclease free water 
before starting the protocol, and whole reactions including SPRI beads in solution 
were applied to the RNA purification column. Reaction products were visualized 
and quantitated with a UV-transilluminator after running 1 μL of IVT product on a 
6% Tris-Borate-Urea (TBU) gel for 20-25 minutes at 250 Volts and staining with 
SYBR gold. For each sample the region from 250 base pairs to 2000 base pairs 
was used for RNA quantitation and determination of the volumes of product 
needed for input into RNA-seq processing, since that portion of the gel is 
amplified RNA product. 50 nanograms of RNA was used for input into RNA-seq 
processing. 
 
RNA-seq (custom transposon mediated fragmentation) 
94 
 
 
For first stranded cDNA synthesis the standard Clontech SMART MMLV reverse 
transcriptase protocol was followed. 2.5 μL of 20 μM random hexamers were first 
added to 50 ng RNA for each sample and incubated at 70°C for 3 minutes then 
cooled immediately on ice. MMLV reverse transcription mastermix was added to 
make a 20 μL total reaction volume, followed by incubation at room temperature 
for 10 minutes, and then 42°C for 60 minutes, and inactivated at 70°C for 10 
minutes. To remove RNA in DNA/RNA hybrids, samples were incubated for 20 
minutes with 0.5 Units/μL RNase H at 37°C. DNA templates were primed with 2.5 
μL 20 μM sss_NPA_prmr (Supplementary Table 5) and incubated for 2 minutes 
at 65°C then cooled immediately on ice. For second stranded synthesis 5.88 μL 
of 5X Taq PCR master mix (NEB) was incubated with samples at 72°C for 8 
minutes. Next, 45 μL nuclease free water was added to reactions, and then 
double stranded DNA was purified with SPRI beads at 1:1.8X ratio (135 μL SPRI 
beads), eluted with 20 μL nuclease free water and then concentrated to ~4 μL in 
a Eppendorf™ Vacufuge™ Concentrator, set to 30°C and spun for approximately 
15 to 18 minutes. Fragmentation and 3’ end tagging of double stranded cDNA 
was simultaneously performed by adding 1 μL tagmentation buffer, and 1 μL 
loaded custom 0.1 μM final in reaction EzTn5 transposomes (ME_BOT, ME_TOP 
(Supplementary Table 5)) to the solution and then incubating at 55°C for 6 
minutes, followed by cooling on ice. The same tagmentation buffer that was used 
in the transposition reaction for tagging open chromatin was used for this 
reaction. 0.14 μM final in reactionTn5059 can also be used in place of EzTn5 and 
would provide better read diversity, however for this experiment we did not have 
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Tn5059 with ME_BOT and ME_TOP available. Also, this transposome complex 
is prepared the same way as described in transposome generation above, 
however with different oligos as specified. Next, samples were incubated with 0.1 
AU Qiagen protease at 50°C for 10 minutes, then 70°C for 20 minutes. Gap fill-in 
was performed by addition of 6 μL of 2X Taq PCR master mix (NEB), and 
incubated at 72°C for 3 minutes. To the sample, 9.0 μL of 2X Taq was added 
with 2 μL of 10 μM of 5’ PCR primer, 2 μL of 10 μM Index barcode primer (for 
each individual unique sample) (Supplementary Table 5), 1.0 μL of 25X SYBR 
green, 4 μL nuclease free water and 12 μL of DNA template for a 30 μL PCR 
reaction. PCR cycling consisted of an initial incubation at 72°C for 3 minutes then 
95°C for 30 seconds and cycling at 95°C for 10 seconds, 63°C for 30 seconds 
and 72°C for 3 minutes until curves reach saturation. Generally, reactions were 
stopped at the end of cycles 9-11. The products of the PCR reactions were 
visualized and quantitated with a UV-transilluminator after running 1 μL of PCR 
product on a 6% Tris-borate-EDTA (TBE) gel for 20 minutes at 250 Volts and 
staining with SYBR gold. Barcoded samples were pooled and gel size selected 
for fragments between ~220-1000 base pairs. Now libraries were ready for 
sequencing. 
 
Custom ATAC-seq 
Transposome complexes were generated at Illumina and provided at 2.5 µM. To 
perform the assay cells were first washed in PBS and then spun down at 500Xg 
for 5 minutes. Cells were then counted with Bio-rad TC-20 cell counter diluted to 
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500,000 cells/mL, and then 1 µL was aliquoted to sample tubes. 1 µL of 2X lysis 
buffer (same as THS-seq) was added to each reaction, followed by 1 µL 5X 
custom tagmentation buffer (same as THS-seq), 1 µL EzTn5 Transposomes and 
1 µL nuclease free water. Reaction was incubated at 37°C for 30 minutes.  Next, 
1 µL of 0.05 AU/mL Qiagen protease is added to the reaction, and incubated at 
50°C for 10 minutes, then 70°C for 20 minutes. Samples are now ready for PCR, 
and 1.50 µL 10 µM barcoded i5 adaptor, 1.50 µL 10 µM barcoded i7 adaptor, 
15.0 µL KAPA SYBR FAST, and 6.0 µL nuclease free water are added to the 
whole reaction (6.0 µL) from the previous step. PCR cycling consisted of an initial 
incubation at 72°C for 3 minutes then 98°C for 30 seconds and cycling at 98°C 
for 10 seconds, 63°C for 30 seconds and 72°C for 1 minute until curves reach 
saturation. Generally, reactions were stopped at the end of cycles 9-11. Samples 
were then cleaned with AMPURE SPRI beads at 1.8X ratio. Samples were 
visualized and quantitated with a UV-transilluminator after running 1 μL of each 
reaction on a 6% Tris-borate-EDTA (TBE) gel for 20 minutes at 250 Volts and 
staining with SYBR gold. Barcoded samples were pooled and gel size selected 
for fragments between ~220-1000 base pairs. Now libraries were ready for 
sequencing. 
 
Primary data Processing 
Sequencing was performed on HiSeq with 50 x 6 single end reads with single six 
base pair indexing for THS-seq data, and 50 x 8 x 8 single end reads with dual 
eight base pair indexing for ATAC-seq data. Technical replicates were combined 
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before analysis, while biological replicates were kept separate. Any down 
sampling of mapped alignments was performed with in house scripts randomly 
sampling reads from the original datasets. Sequencing reads were first mapped 
to the hg19 reference genome with BWA 0.7.5a-r405 using default parameters. 
After conversion to a bam file with samtools, clonal read removal was performed. 
For identifying significantly enriched regions, Dfilter was used with default 
parameters, unless stated. Overlaps were calculated using the bedtools function 
coverageBed. Individual loci read density data were extracted from BAM files, 
and converted to wig files and examined as a custom tract on the UCSC genome 
browser. Correlations were performed and graphed in R, and peak distribution 
graphs among other graphs were graphed with graphpad prism version 5.0. 
Proportional Venn diagrams were generated with Venn Diagram Plotter, 
(http://omics.pnl.gov/software/venn-diagram-plotter). Gene ontology analyses on 
significantly called peaks were performed with GREAT43. 
 
Counting the number of alignments in peaks 
Files with significantly called peaks generated by Dfilter were used to obtain 
peaks regions called for each sample. To count all alignments in peaks, the 
function “samtools view –Lh bam_files bed_region >> output“ was used to output 
and concatenate alignments overlapping the input BED peaks file to a new file, 
followed by counting the number of reads total in the outputted file. To count 
alignments in each individual peak, the function “samtools view –Lh bam_files 
bed_region > output“ was used for each individual peak, and then the number of 
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alignments in each peak region was counted. To get the normalized number of 
reads per 100 base pairs, first any peaks that had zero alignments were 
removed, and then the total number of reads for each peak was divided by 100. 
Each dataset was sorted first by the number of reads per 100 base pairs, and 
then by peak length before plotting in excel or graphpad prism version 5.0. For 
calculating the mean ± SEM, datasets with the normalized number of reads per 
100 base pairs were saved as CSV files with peak length in the first column, and 
reads per 100 base pairs in the second column, and then run through an in 
house python script calculating the mean ± SEM for each peak length, with each 
peak length being in increments of 100 base pairs. Results were then graphed in 
Graphpad Prism version 5.0. 
 
Published ENCODE data analysis 
Duke and UW ENCODE GM12878 lymphoblastoid datasets were downloaded 
from the UCSC genome browser (data accessible at NCBI GEO database72, 
accessions GSM816665, GSM736496, GSM736620) and were processed using 
the same pipeline used to process THS-seq and ATAC-seq data, except bowtie 
version 1.0.0 with stringent parameters (bowtie -n1 -k1 --best --chunkmbs 10240 
--strata -l32 -m1 -p4 --nomaqround –sam) was used for mapping. To get the 
most comprehensive accessibility data from Duke and UW, all replicates from 
each respective dataset were combined before mapping. In total, 144,738,228 
and 47,417,059 total unique alignments were used for analysis for Duke and UW 
respectively.  
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Published ATAC-seq data analysis 
All raw paired end ATAC-seq data for 50,000 cells and 500 cells was 
downloaded from GEO gene expression omnibus (data accessible at NCBI GEO 
accession GSE47753). Only read 1 of the paired end data was used for analysis 
to provide a fair comparison to single end THS-seq data. ATAC-seq read 1 
datasets were then aligned with BWA using default parameters. Down sampling 
of mapped alignments was performed with in house scripts randomly sampling 
reads from the original datasets, and then run through Dfilter for calling of 
significant peaks. 
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APPENDIX B: scTHS-SEQ MATERIALS AND METHODS 
Sample Origin and Nuclei Preparation 
All human tissue protocols were approved by the Scripps Office for the Protection 
of Research Subjects (SOPRS) at The Scripps Research Institute (TSRI) and 
conform to National Institutes of Health guidelines.  Nuclei were prepared using 
nuclear extraction buffer (NEB) as described previously (7).  Briefly, fresh frozen 
post-mortem brain tissue was sectioned at 50um using a cryostat and placed in 1 
ml of ice-cold NEB for 10 minutes.  Nuclei were extracted using a glass dounce 
homogenizer with Teflon pestle using 10-12 up-and-down strokes in 1 ml of NEB.  
Samples were passed through a 50um filter (Sysmex Partec), incubated on ice 
for 10 minutes.  Samples were spun for 5 minutes at 250-300 x g, washed in 
PBS + 2 mM EGTA (PBSE), and resuspended in PBSE supplemented with 1% 
fatty-acid free bovine serum albumin (FAF-BSA, Gemini) containing 4',6-
diamidino-2-phenylindole (DAPI).  DAPI+ single nuclei were purified by flow 
cytometry using MoFlo Astrios (Beckman Coulter), concentrated at 900g for 10 
minutes and used directly for droplet encapsulation.  
  
Nuclei encapsulation, mRNA-Seq Library Preparation and Sequencing 
Drop-seq was performed as described previously32, but with modifications 
optimized for processing nuclei, now termed snDrop-seq.  Before droplet 
generation, connecting tubing and syringes were coated with 1% bovine serum 
albumin (BSA) to prevent non-specific binding of nuclei to the surface, and then 
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rinsed with PBS. To reduce nuclei settling, Ficoll PM-400 was added to nuclei 
suspension buffer, rather than the lysis buffer. Nuclei were loaded at the 
concentration of 100 nuclei/ml, and co-encapsulated in droplets with barcoded 
beads purchased from ChemGenes Corporation, Wilmington MA (Cat. # 
Macosko201110). When encapsulation was complete, the droplet-collecting 
falcon tubes were added with a layer of mineral oil, and then transferred to 72°C 
water bath. After 5 minutes of incubation, the tubes were removed from the water 
bath to ice and droplets were broken by perfluorooctanol, following which beads 
were harvested, and hybridized RNA was reverse transcribed. cDNA was then 
PCR amplified for 16 cycles with primer, buffer and cycle conditions identical to 
those described previously (2). A total of 32 libraries were prepared from 14 
experiments, and cDNA from each replicate was prepared and tagmented by 
Nextera XT and indexed with different Nextera index 1 primers. cDNA libraries 
were pooled and sequenced on the Illumina Hiseq 2500 using Read1CustSeqB 
(2) for priming of read 1 (read 1 was 30 bp; read 2 (paired end) was 120 bp). 
  
snDrop-seq data processing 
Paired-end sequencing reads were processed largely as described 
(http://mccarrolllab.com/wp- content/uploads/2016/03/Drop-
seqAlignmentCookbookv1.2Jan2016.pdf) with additional correction steps. First, 
paired-end reads were filtered out if read 1 had more than 4 non-T bases in the 
last 10 bases (to remove all non poly T-captured contaminated reads), or had 
one or more bases with poor quality score (less than 10). And cell barcode and 
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UMI information were then inferred from the first 12 bases and the next 8 bases 
of read 1 respectively. The right mate of each read pair was trimmed to remove 
any portion of the SMART adaptor sequence or large stretches of polyA tails (6 
consecutive bp or greater). The trimmed reads were then aligned to the human 
genome (GENCODE GRCH38) using STAR v2.5 with the default parameter 
settings. Reads mapping to intronic or exonic regions of genes as per the 
GENCODE gene annotation were both recorded. One further correction step to 
fix barcode synthesis errors was performed by inserting N at last base of the cell 
barcode for reads which had identical first 11 bases of the cell barcode and same 
last T base of UMI. Digital expression matrix was then generated with genes as 
rows and cells as columns. UMI counts were assigned for each gene of each cell 
by collapsing UMI reads which had only 1 edit distance.  
  
snDrop-seq Data Clustering and Analyses 
UMI matrix cell barcodes were tagged by their associated sequencing library 
batch ID (Table 6) and combined across independent experiments.  
Mitochondrial genes not expressed in nuclei were excluded and only UMI counts 
associated with protein-coding genes were used for clustering analyses. Nuclei 
with fewer than 300 molecules or more than 5,000 molecules (outliers) were 
omitted. Molecular counts were normalized using the total number of reads, as 
the estimate of library size for each cell. The expression values were rescaled so 
that mean expression of a gene within each measurement batch was equal to the 
dataset-wide average. Winsorization procedure was used to cap the magnitude 
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of 10 most extreme values for each gene. To estimate the residual variance for 
each gene, variance dependency on the expression magnitude (log scale) was 
modeled as a smoothed generalized additive model with smoothing term k=10 
(using mgcv package in R). The observed to expected variance ratio for each 
gene was modeled using F distribution using the degrees of freedom 
corresponding to the number of successful gene observations. To normalize the 
contribution of each gene in the subsequent PCA analysis, the variance of each 
gene was rescaled to match the tail probability obtained from the F distribution 
under a standard normal sampling process. For both the visual cortex dataset, 
cell clusters were determined using approximate k-nearest neighbor graph (k=50) 
based on a cosine distance of the top 150 principal components (PCs) derived 
from the top 1500 variable genes from the variance-adjusted expression matrix, 
using the infomap community detection algorithm (as implemented in the igraph 
R package). Cell clusters with fewer than 30 cells were omitted from further 
analysis. Similarly, for the smaller frontal cortex dataset, cell clusters were 
determined using a smaller k=30 based on the consine distance of the top 100 
PCs derived from the top 2000 variable genes. Cluster stability was assessed 
using 85% subsampling. For both datasets, Cluster1 grouped low-depth cells that 
could not be confidently assigned to other clusters, and was omitted. Resulting 
cells were reclustered and visualized using t-Distributed Stochastic Neighbor 
Embedding (t-SNE) on the 150 PCs using a perplexity of 100 for the visual cortex 
dataset and on the 100 PCs using a perplexity of 300 for the frontal cortex 
dataset. 
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Violin plots and differential gene expression analyses were performed 
using Seurat software (V1.4.0.5) in R (https://github.com/satijalab/seurat).  For 
normalization, UMI counts for all annotated nuclei were scaled by total UMI 
counts (excluding mitochondrial genes), multiplied by 10,000 and transformed to 
log space.  Technical effects associated with UMI coverage and batch identity 
were regressed from scaled data using a linear model (RegressOut function in 
Seurat).  Cell type and subtype enriched genes were identified (Seurat software) 
using a likelihood-ratio test on all protein-coding genes to identify 0.25 fold (log 
scale) enriched genes detected in at least 25% of cells in the cluster.  Gene 
enrichment analyses were performed for all clusters and for excitatory or 
inhibitory neuron subtypes separately.  
 
Comparison of snDrop-seq Data with Published Data 
Control bulk RNA-seq data (FPKM values) from the mouse cerebral cortex and 
human temporal lobe were obtained from: 
http://web.stanford.edu/group/barres_lab/brain_rnaseq.html and 
http://web.stanford.edu/group/barres_lab/brainseqMariko/brainseq2.html, 
respectively.  Top 50 cell type enriched genes were derived from comparison of 
averaged expression values of each cell type against an average of the 
remaining cell types (with the exception of oligodendrocyte sub-populations 
which were compared only against non-oligodendrocyte lineages).  Type 
enriched genes from bulk data sets were used for correlation of log averaged 
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FPKM values of the associated bulk RNA-seq data with log transformed average 
expression values from snDrop-seq data.  
  For comparison with single-cell RNA-seq data from the human temporal 
lobe52, gene count data was obtained from GEO (GSE67835), normalized using 
Seurat as mentioned above using a minimum cutoff of 1000 genes detected.  
Highly variable genes were identified from a mean variability plot (average 
expression versus dispersion (Variance/mean) assigned to 20 bins based on 
average expression) using a log(Variance/mean) cutoff of 1 to identify 2235 
genes.  Principle component analysis (PCA) was performed on these highly 
variable genes then projected to the entire dataset.  Statistically significant PCs 
(p value < 0.05) were identified using a jack straw approach.  Cell identities from 
the original publication were maintained and the top 50 genes from the 
statistically significant principal components differentiating these cell types, as 
well as the top 10 differentially expressed genes associated with each cell type, 
were identified using Seurat and used for correlation of log transformed averaged 
expression values from scRNA-seq and snDrop-seq data.  For comparison with 
single cell RNA-seq data from the mouse visual cortex51, gene RPKM data was 
obtained (GSE71585), log transformed and loaded into Seurat using published 
cluster annotations.  Neuronal subtypes were combined into a single group and 
average cluster expression values were obtained across cell types using 
previously described marker genes present in each cluster51 and a correlation 
heatmap of log transformed averaged expression values was generated.  SNS 
data generated on the Fluidigm C1 platform53 (dbGaP accession 
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phs000833.v3.p1) were used for correlation of log transformed subtype-averaged 
expression values for differentially expressed genes (greater than 2-fold) 
underlying previous subtype clustering and classification53 combined with the top 
10 cluster-specific markers for the visual or frontal cortices (Table 8).  For 
comparison of subtypes between visual and frontal cortex data, correlation of log 
transformed subtype-averaged expression values for the top 10 marker genes for 
each region were used.  
  For comparison of UMI counts and genes detected with scDrop-seq data 
from the mouse retina (2), the full UMI count table for 44808 annotated samples 
was obtained from GEO (GSE63472).  For comparison with 9k brain cell data 
sets from an E18 mouse generated on the 10X platform (Cell Ranger 1.3., v2 
Chemistry), filtered gene matrices were downloaded from the company website. 
For comparison with human embryonic midbrain single cell data sets generated 
using the Fluidigm C1 platform55, annotated UMI count matrices were obtained 
from GEO (GSE76381).  Each data set was analyzed using Seurat for t-SNE 
visualization of clusters.  
  
RNA In Situ Hybridization (ISH) 
For RNA ISH from the visual cortex (Fig. 2), representative images were 
obtained from the Allen Human Brain Atlas (http://human.brain-map.org) and 
corresponding links are provided in Table 11. 
 
scTHS-seq Sample Origin and Nuclei Preparation 
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The same human tissue samples use in used in snDrop-seq were used for 
scTHS-seq. However, after flow cytometry nuclei were processed differently and 
were always kept on ice. Nuclei were spun down at 500xg for 5 minutes at 4ºC, 
then supernatant was removed, and the pellet was resuspended in 1X lysis 
buffer (1X concentration: 10 mM Tris-Hcl pH 7.4, 10 mM NaCl, 3 mM MgCl2 0.1% 
NP-40, 2% bovine serum albumin, one roche protease inhibitor tablet per 10 mL, 
in PBS) and chilled at 4ºC for 5 minutes without shaking. Then nuclei were spun 
down at 500xg for 5 minutes, supernatant was removed, and the pellet 
resuspended in 1.5X tagmentation buffer (1.0X concentration: 33 mM Tris-OAc, 
pH 7.8, 66 mM K-OAc, 10 mM Mg-OAc, 16% Dimethylformamide). Now the 
nuclei sample was ready for nuclei counting and species/species sample mixing. 
For running scTHS-seq, a mouse nuclei sample and a human nuclei sample was 
always mixed. The mouse nuclei sample was prepared the same way after flow 
cytometry. For species/species mixing, both the human nuclei and mouse nuclei 
samples were counted on a Bio-Rad TC20 cell counter, and diluted with 1.5X 
tagmentation buffer, or further concentrated by spinning down nuclei at 500xg for 
5 minutes at 4ºC and resuspending in a lower volume with 1.5X tagmentation 
buffer, so the samples cell counts were within 10% of each other. A cell 
concentration of ~2.4X105 nuclei/mL was obtained for each sample with the 
optimal range being 2.0X105 – 5.0X105 nuclei/mL with ~1 million total nuclei for 
each sample. Next, equal volumes mouse and human samples were combined, 
and mixed gently. The sample was now ready for transposition and combinatorial 
indexing. 
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scTHS-seq transposon generation 
Each transposon consisted of two oligos synthesized by IDT and kept at 100 µM 
stock solutions in TE buffer, the 74 base pair barcoded transposon and 19 base 
pair universal 5’ phosphorylated mosaic end. In total there were 384 barcoded r5 
transposons each with a unique 6 base pair barcode and all barcodes in the 
barcode set had a minimum edit distance of 2 (Table 17). In order to generate 
the annealed transposons, 10 µL of each 100 µM oligo was aliquoted into one 
reaction for a total of 384 uniquely barcoded r5 transposon reactions in a 384 
well plate with one uniquely barcoded r5 transposon per well. The 384 well plate 
was incubated at 95ºC for two minutes, and cooled to 14ºC at 0.1ºC/second. 
Each uniquely barcoded annealed r5 transposon was now at 50 µM in 20 µL, and 
was then diluted to 8.4 µM and a final concentration of 50% glycerol in a new 384 
well plate. Dilution was with a solution of TE and 75% glycerol. Transposons 
were stored at -20ºC. 
  
scTHS-seq barcoded r5 transposome complex generation 
Tn5059 was generated at Illumina, and normalized for activity before being 
received. It is important to note complexed Tn5059 and transposon slowly 
degrades transposon over time, with noticeable loss in data quality after a few 
weeks, however uncomplexed components have a long shelf life. Because of 
this, r5 transposome complexes were generated the morning scTHS-seq was 
going to be run. All steps were performed with the E1-Cliptip programmable 12 
109 
 
 
channel electronic pipettor. First, Tn5059 was diluted to 4.2 µM in standard 
storage buffer provided by Illumina. In a 384 well plate, 1 µL of 4.2 µM Tn5059 
was added to each well. Next, 1 µL of 8.4 µM annealed barcoded r5 transposon 
was added to each well and mixed, with one uniquely barcoded r5 transposon 
per well. Activity normalization performed by Illumina found twice the transposon 
concentration to Tn5059 concentration was needed for comparable activity, due 
to a longer transposon being used. The 384 well plate was then incubated at 
room temperature for 30 minutes, and was then ready for tagmentation and 
combinatorial indexing. 
  
scTHS-seq custom i7 transposome complex generation 
For custom nXTv2_i7 Tn5059 transposome generation, first annealed 
transposon at 50 µM was generated as described above with the nXTv2_i7 
transposon (Table 17). To generate a complexed transposome solution of 1.75 
µM Tn5059 and 2.5 µM annealed transposon, 3.5 µM Tn5059 was incubated 
with 5 µM annealed transposon for 30 minutes at room temperature. Then the 
complexed transposome solution was diluted to 0.7 µM with standard storage 
buffer provided by Illumina, and was now ready for tagmentation. Transposome 
complexes were stored at -20ºC and used within a week. 
  
scTHS-seq nuclei tagmentation and barcoding 
To the 384 well plate of freshly generated uniquely barcoded Tn5059 r5 
transposome complexes, 4 µL of human/mouse mixed cell sample was added for 
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a total of ~960 nuclei/well and final concentration of 0.7 µM Tn5059 r5 
transposome complex. Each sample was mixed gently 5X by the electronic 
pipettor. Optimally ~2000 nuclei/well are wanted, however nuclei yields were low. 
The 384 well plate was then incubated at 37ºC for 30 minutes. To stop the 
reaction, 4.0 µL of 50 mM EDTA was added to each well and mixed gently 5X by 
the electronic pipettor for a final concentration of 20 mM EDTA in 10 uL, followed 
by incubating the 384 well plate at 37ºC for 15 minutes. The 384 well plate of 
samples was then frozen at -20ºC overnight. The next day, the 384 well plate of 
samples was thawed, and one volume of cold 2X FACS buffer (1X FACS buffer: 
2 mM EDTA, 1% BSA in PBS) was added to each well. Samples are then mixed 
gently 3X by the electronic pipettor and pooled into one tube on ice, which was 
spun down at 500xg for 5 minutes at 4ºC. Supernatant was removed, and 
tagmented nuclei resuspended in 1.5 mL cold 1X FACS buffer. Next, 75 µL 
eBioscience Propidium Iodide (PI) was added to the tube, and gently mixed. 
Nuclei were then sorted by flow cytometry into 96 well plates containing 10 µL 
PBS/well at 100 nuclei/well, and put on ice. Doublets were removed based on 
forward and side scatter plots, and PI stained events selected. Nuclei were now 
ready for RNA amplification and processing. 
  
scTHS-seq library preparation 
Each 96 well plate of nuclei was processed individually. First, 11 µL guanidine 
hydrochloride was added to each well and mixed by lightly vortexing. Reactions 
were purified by addition of 40 µL (1.8X) AMPure SPRI beads and lightly 
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vortexed, then bead pelleting and 80% ethanol washes were performed with the 
“flick and blot” method and magnetic plate from V&P Scientific. After 80% ethanol 
washes were complete the plate was quickly spun down at 500xg and leftover 
80% ethanol removed by pipetting. 10 µL 1X NEB Taq polymerase was added to 
each reaction and the plate was lightly vortexed to resuspend the beads (SPRI 
beads left in reaction), followed by running the reactions at 72ºC for 3 minutes for 
end fill in and put on ice. For in vitro transcription (IVT) amplification the NEB 
HiScribe T7 high yield synthesis kit was used. To each reaction a mastermix of 2 
µL of 10X transcription buffer, 2 µL ATP, 2 µL CTP, 2 µL GTP, 2 µL UTP was 
directly added to the end fill in reactions, lightly vortexed, and incubated at 37ºC 
for 19 hours. To check IVT amplification, two full reactions were purified with 
SPRI binding buffer, run on a 6% Tris-Borate-Urea (TBU) gel for 20 minutes at 
250 volts followed by SYBR gold staining and visualization on a UV-
transilluminator. Next, reactions were purified by addition of 44 µL (2.0X) SPRI 
binding buffer (20% PEG 8000, 2.5 M NaCl, 10 mM Tris–HCl, 1 mM EDTA) to 
each reaction and the plate vortexed thoroughly. 80% ethanol washes and 
leftover 80% ethanol removal were performed as describe above, and SPRI 
beads were resuspended in 9 µL nuclease free water. For reverse transcription, 
first 2.5 µL of 20 µM random hexamers was added to each reaction, the plate 
vortexed lightly and then heated to 70ºC for 3 minutes, and immediately cooled 
on ice. Then Clontech SMART® MMLV Reverse Transcriptase kit was used with 
addition of 4 µL 5X first strand synthesis, 2 µL dNTP mix, 2 µL 100 mM DTT, 0.5 
µL SMART MMLV RT in a mastermix to each reaction and the plate vortexed 
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lightly. Reactions were incubated at 22ºC for 10 minutes, then 42ºC for 60 
minutes, and terminated at 70ºC for 10 minutes. To degrade RNA in cDNA-RNA 
hybrids 1 µL of 0.5 units Enzymatics RNase H was added to each reaction, the 
plate was vortexed lightly and incubated at 37ºC for 20 minutes. For second 
strand synthesis first 2.5 µL of 20 µM sss_scnXTv2 (Table 17) was added to 
each reaction and lightly vortexed, then incubated for 2 minutes at 65ºC and 
immediately cooled on ice. Then 5.9 µL of NEB taq5X was added to each 
reaction and incubated at 72ºC for 8 minutes. After cooling on ice, 60 µL (2.0X) 
SPRI binding buffer was added to each sample. The plate was vortexed 
thoroughly and 80% ethanol washes and leftover 80% ethanol removal 
performed as described previously, and SPRI beads resuspended by light 
vortexing in 7 µL of nuclease free water. Double stranded cDNA fragments then 
undergo simultaneous fragmentation and 3’ adaptor addition with a custom 
nXTv2_i7 Tn5059 transposome (Table 17). To 7 µL of sample, 2 µL of 5X 
tagmentation buffer was added to each sample, followed by addition of 2 µL of 
prepared 0.7 µM custom nXTv2_i7 Tn5059 transposomes (final transposome 
concentration of 0.14 µM), vortexed lightly, then incubated at 55ºC for 6 minutes, 
and cooled briefly on ice. Immediately after cooling, 19 µL of 6.32M guanidine 
hydrochloride, for a final guanidine hydrochloride concentration of 4M was added 
to each reaction and briefly vortexed. Then 60 µL (2.0X) SPRI binding buffer was 
added to each sample. The plate was vortexed thoroughly and 80% ethanol 
washes and leftover 80% ethanol removal was performed as described 
previously. However, for this purification SPRI beads were resuspended in 16 µL 
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nuclease free water and the plate was placed back onto the magnetic plate. 
Sample was eluted off SPRI beads held by the magnetic plate, and transferred to 
a qPCR plate. Standard Illumina Nextera XT v2 barcoding in an 8x12 (i5xi7) 
format was performed with qPCR, using custom scTHS-seq i5 indexes and 
standard Illumina i7 indexes (Table 17). In total, 20 µL of KAPA SYBR Fast, 2 µL 
of 10 µM scT7_S5XX index primer and 2 µL of 10 µM nXTv2_i7XX index primer 
were added to each reaction for a total volume of 40 µL, and mixed well. qPCR 
was run at 72ºC for 3 minutes, 95ºC for 30 seconds, followed by cycling for (95ºC 
for 10 seconds, 63ºC for 30 seconds, 72ºC for 1 minute) until curves reach 
saturation, typically 9-12 cycles. Plates were stored at -20ºC. 
  
scTHS-seq library validation, pooling and sequencing 
To validate libraries, 1 µL of each qPCR reaction was run on 6% Tris-borate-edta 
(TBE) gels at 250 volts for 20 minutes, staining with SYBR Gold, and visualizing 
smears with a UV-transilluminator. For pooling, 2 µL of each of each uniquely 
barcode qPCR reaction was added to one tube. If smears on TBE gels were 
visibly significantly lighter, then 4 µL or 6 µL of the reaction was added to the 
pooled sample. After all samples had been added, the pooling tube was mixed 
thoroughly. For gel size selection a TBE gel of the pooled sample was run at 250 
volts for 20 minutes and size selected from 220-1000 base pairs with a Dark 
Reader blue light transilluminator, and scalpel. Selected bands were sheared by 
poking a hole in the bottom of a 0.5 mL tube with a 22-gauge needle, placing the 
gel piece inside then placing the 0.5 mL tube into a 2.0 mL tube, and centrifuging 
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in a bench top centrifuge at 21,000xg for 1 minute. Next the 0.5 mL tube was 
removed, 450 µL 1X TE added then shaken vigorously at 37ºC for 45 minutes. 
The supernatant and all possible retrievable liquid was pipetted into Nanosep 0.2 
µM filter tubes and centrifuged at 21,000xg for 1 minute. Collected sample in the 
nanosep tube then underwent ethanol precipitation, with 40 µL NaOAc, 1.3 µL 
Ambion GlycoBlue, and 1 mL 100% Ethanol added to each tube. Samples were 
mixed gently and put at -80ºC for 15 minutes, followed by centrifuging at 
12,000xg at 4ºC for 20 minutes. Supernatent was discarded and 700 µL ice cold 
75% ethanol added. Sample was inverted for mixing, then centrifuged at 
18,000xg for 5 minutes at room temperature. Supernatent was discarded, 
leftover ethanol pipeted out, pellet dried, and pellet resuspended in 5 µL 
nuclease free water. Resultant size selected libraries were quantified with Qubit, 
sequenced on Illumina MiSeq (50x32x32) single end reads for validation, then 
Illumina HiSeq 2500 high throughput (50x8x32) single end reads for data 
generation. 
  
scTHS-seq data processing 
Raw BCL files were demultiplexed to fastq files Read1, Index1, and Index2 files 
using bcl2fastq v2.17.1.14, then used as input to deindexder 
(https://github.com/ws6/deindexer) with 0 mismatch barcode demultiplexing. 
Barcode combinations associated with each read were appended to each reads 
header with in house perl scripts and all fastq’s were combined and mapped to a 
hg38 no alternative loci plus decoy reference genome 
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(GCA_000001405.15_GRCh38_no_alt_plus_hs38d1_analysis_set) and mm10 
no alternative loci reference genome 
(GCA_000001635.5_GRCm38.p3_no_alt_analysis_set) using BWA 0.7.12-
r1039. Mapped sam outputs were redemultiplexed by barcodes, converted to 
bam files and clonal reads removed with samtools 1.3.1, while gathering read 
statistics for each barcode combination. To determine which uniquely barcoded 
nuclei were suitable for downstream analysis, several dataset filtering steps were 
implemented. First, all multimapping reads MAPQ<5 were removed from each 
single cell dataset to remove reads in repeat regions, and to remove biases 
before clustering. Second, nuclei were filtered requiring log10(total reads + 1) > 
3.  To better focus on potential microglial cells, an additional analysis without 
multimapping reads removed was also conducted with the same nuclei filtering 
criteria.  
Joint peak calling was performed on pooled bam files using SPP (v1.13; 
https://github.com/hms-dbmi/spp). In total, 14781 cells were pooled. Reads 
mapping within 100bps of known repeat regions according to annotations from 
Repeat Masker (http://www.repeatmasker.org) were removed. A smoothed 
density of pooled reads was generated using window tag counts with a window 
size of 500bps and a window step of 100bps. DNA accessible regions (peaks) 
were called based on the smoothed density with a minimum threshold of 5 reads 
and minimum span of 5 steps between each peak. Peaks were filtered using a 
permutation based FDR of 10e-8 and filtered for presence in at least 40 cells 
from the visual cortex, resulting in 52694 final peaks called (Table 13). Called 
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peaks were then assessed for reads in each individual cell to generate a matrix 
of peaks versus cells for downstream clustering and analysis. 
 
scTHS-seq Data Clustering 
The molecular count matrix was binarized for further analysis. 52,694 sites that 
were observed in 30 or more cells were selected. The data was modeled as a 
right-censored Poisson process (observing at most 1 molecule per site). To 
determine cell depth and batch-specific site observation probabilities, an EM 
algorithm was used, with each iteration fitting MLE values for library size and 
batch-specific site probabilities sequentially. To evaluate over-dispersion of each 
site, total deviance was calculated across all observations was calculated for a 
given site under the censored Poisson process. The relationship between the 
total deviance and mean site occurrence frequencies was modeled using 
generalized additive model (mgcv R package, smoothing term k=10). The 
observed / expected deviance difference was scored using variance gamma 
distribution.  
To cluster and visualize the cells in the visual cortex, top 30 PCs were 
determined on the censored Poisson deviance residual matrix. The negative 
deviance residuals associated with non-observed sites were ignored. Cell 
clusters were determined on a k-nearest neighbor graph (k=50) using multilevel 
community detection method (igraph R package). Cell clusters with fewer than 30 
cells were omitted from further analysis. Upon inspection, three smallest clusters 
appeared to represent poorly-resolved cells or doublets mixing signals from two 
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or more subpopulations and were also not examined in further analysis. Two 
dimensional visualization was achieved by applying t-Distributed Stochastic 
Neighbor Embedding (t-SNE) on the 30 PCs using a perplexity of 50.  
The 30 PCs derived from the visual cortex were also used to project cells from 
the frontal cortex. Due to there being fewer cells in the frontal cortex dataset than 
the visual cortex dataset, a smaller k=30 and perplexity of 30 was used for the k-
nearest neighbor graph and t-SNE embedding respectively.  
 
scTHS-seq collision rate determination 
For each unique barcode combination, the proportion of unique reads that map to 
either mouse or human genome was calculated. A unique barcode combination 
was determined to belong to one species if 89% of the reads mapped to one 
genome, otherwise the barcode combination was determined to be a detectable 
collision. For visualization, results were then graphed in R using a X,Y scatter 
plot and density plot. 
 
scTHS-Seq and snDrop-Seq joint analysis 
To map between transcriptional and epigenetic space we trained a generalized 
boosted regression model (GBM) to predict the probability of differential 
expression from patterns of nearby accessibility differences, and a separate 
GBM in reverse, predict probability of differential accessibility given the 
differential expression observations. GBM was implemented using the caret 
(V6.0-72) package in R. The differential expression prediction GBM utilized the 
118 
 
 
following features: 1) maximum differential accessibility Z score observed within 
5kb of the transcription start site; 2) maximum differential accessibility Z score of 
any site located within the gene or within 3kb of the gene boundaries; 3) number 
of differentially accessible (Z>5) sites within 3kb of the gene; 4) number of non-
differentially accessible sites within the 3kb of the gene (Z<1).  The differential 
site prediction GBM was based on the following features: 1) distance to closest 
transcription start site; 2) expression difference Z score of the genes with TSS 
within 5kb of the site; 3) max log2 fold expression difference of the gene with 
TSS within 5kb of the site; 4) minimum distance to a gene (0 if the site is 
overlapped by a gene); 4) maximum Z score of differential expression of any 
gene within 3kb of the site. Models were trained on Astrocyte and 
Oligodendrocyte data from the visual cortex only to learn relevance of features. 
Models were fit using 10x cross-validation. Joint scores (across multiple genes or 
sites) were calculated as probability means of individual elements (sites or 
genes). In the first round of mapping, differentially accessible sites for each major 
cell type including Ast, Oli, Ex, In, as well as Mic, Oli, and End combined with Per 
(when available) were identified using a Fisher’s exact test. Joint scores across 
resulting predicted differentially expressed genes were then derived for each 
major cell type for each cell. ROC curves and AUC were computed by comparing 
the resulting joint scores with original annotations. In additional rounds of 
mapping, we restricted to cells predicted to be either Ex or In in order to identify 
additional excitatory and inhibitory subtypes.  
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scTHS-seq transcription factor analysis 
To infer relevant transcription factors (TFs) and transcription factor binding sites 
(TFBSs), we obtained DNA sequences corresponding to scTHS-seq peaks and 
position weight matrices (PWMs) 379 TFs from the JASPAR database. A sliding 
window was used to identify the maximum PWM score for each peak, taking into 
consideration both the plus and minus strands. PWM scores within each peak 
were normalized by subtracting the theoretical minimum and dividing by the 
maximum score possible for each PWM using the PWMscoreStartingAt() function 
from the matchPWM package in R assuming a uniform prior distribution on all 
nucleotides. Scores for each peak as well as TF were then standardized to Z-
scores by subtracting the mean and dividing by the standard deviation of scores 
for each TF to control for background rates of binding and non-specificity. TFBSs 
were inferred as corresponding to peaks with Z-score > 1.96 for each TF. We 
assess the overlap of inferred TFBSs with previously identified cell type specific 
peaks using a Fisher’s exact test. TFs with TFBSs significantly overlapping with 
cell type specific peaks (Bonferroni corrected P-value < 0.2) were inferred to be 
relevant to the cell type. We integrate snDrop-Seq data to assess the expression 
fold change of these TFs in each cell type, assessing significance by using rank-
based gene set enrichment analysis (GSEA). Specifically, TF expression was 
averaged across cells for each cell type. A log2 fold change comparing the 
average expression in oligodendrocyte versus neuronal cell types was used to 
assess for enrichment of expression for predicted oligodendrocyte-related TFs. 
120 
 
 
GSEA was performed using the LIGER package in R 
(https://github.com/JEFworks/liger).  
  
scTHS-seq GWAS data analysis 
GWAS SNPs were downloaded from the GRASP database, using categories 
with any trait for selection with p-values <1x10-6. Categories that were selected 
Alzheimer’s disease, Schizophrenia, Parkinson’s disease, Bipolar disorder, 
Autism, Multiple sclerosis, ADHD, ALS, Epilepsy, Depression, Glaucoma, 
Crohn’s disease, Celiac disease, Type I diabetes, Lung disease, Chronic kidney 
disease, Prostate cancer. For the rest of the analysis in house python and shells 
scripts were used. For each category all SNPs were extended at each end to 
encompass a 100 KB region. Any SNP regions overlapping each other were 
merged with bedtools to generate a larger SNP region containing both SNPs. 
Next, for each SNP region, the most significant p-value SNP was selected. This 
removed any multiple instances of linked variants for the same trait, and ensured 
there were no variants in linkage disequilibrium. Next, the top 50 most significant 
p-value SNPs and their gene regions were selected for further analysis. To 
determine overlap of accessible regions in each cluster defined during cell 
clustering and identification, first peak calling with SPP v1.2 was performed on 
merged data of each cluster to generate list of peak regions, and then lists of 
differential peaks (peaks present in one or more cell types and not others) were 
generated for all the cell types. Peaks with Z-scores <400 were removed to 
generate a final peak list for each cluster. Next, those peaks were overlapped 
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with the top 50 SNP regions for each disease category and the number of 
overlaps counted. To determine if enrichment was significant, Z-scores were 
calculated. First, 20,000 permutations of the peak regions over the hg38 
reference genome using only autosomes was performed, and for each 
permutation overlaps of peaks for each cluster with SNP regions was counted. 
From the permutations, averages and standard deviation were calculated, and in 
conjunction with previously calculated total overlaps, the Z-score for each cluster 
was calculated. For visualization, R was used to overlap Z-scores onto the 
clusters, and generate a heat map of similarity between cell types and diseases. 
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